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This study examined the prevalence rate of obstructive sleep apnea (OSA) as an 
independent variable in association with hypertension as an outcome.  Studies conducted 
outside of the United States suggest that differences in craniofacial features among 
middle-aged Asians increase the prevalence of OSA in comparison to Caucasians with 
similar age and lower BMI.  No similar study had been conducted in the United States.  
The sufficient component cause theory guided this study and was able to describe the 
association between OSA and hypertension among middle-aged Asians.  The objective of 
this cross sectional retrospective study was to determine the prevalence rate of OSA and 
the association between OSA and hypertension among a sample of 462 middle-aged 
Asian patients.  Also, the study evaluated the association of 8 clinical parameters: age, 
gender, smoking, body mass index, Mallampati score, Epworth Sleepiness Scale and 
Apnea-Hypopnea-Index, and hypertension.  The logistic regression analysis showed that 
OSA is associated with hypertension.  The model containing the 8 variables was 
statistically significant, x2 (8, N = 462) = 139.59, p < .000).  Age was the strongest 
predictor among the 8 variables.  This study showed that OSA is common among middle-
age Asians.  This research may necessitate the need to evaluate to change current medical 
awareness, diagnosis, and treatment of OSA and hypertension among Asians, which 
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Chapter 1: Introduction to the Study 
Introduction 
Hypertension, the most important modifiable and major risk factor for adverse 
cardiovascular disease (CVD) affects approximately 70 million people in the United 
States (Roger et al., 2012).  However, it has been suggested that some racial and ethnic 
groups have much higher rates of hypertension than the general population (Mirrakhimov 
et al., 2013; Yoon et al., 2010).  These variations in prevalence in cardiovascular risk 
factors also occur among subgroups (Egan et al., 2010).  Hypertension prevalence rates 
differ among subgroups of the Asian population (Watson et al., 2009).  In the 
MultiEthnic Study of Atherosclerosis (MESA study), the rate of hypertension among 
Chinese (n = 803) was 35.2 (Moran et al., 2007).  The Pan Asian Cohort Study (2013) 
revealed that the age-and sex-adjusted prevalence rate of hypertension among various 
Asian subgroups compared to Non-Hispanic Whites using electronic medical records of 
216,768 patients over 18 years of age was 34.9% (99% CI, 34.5-35.3%) versus 38.9% 
(99% CI, 38.6-39.2%; Powell et al., 2013).  The adjusted hypertension rates were 51.2 % 
(50.7-53.2%) for Filipinos, 29.8% (29.1-30.4%) for Chinese, 30.7% (28.0-33.5%) for 
Koreans, 30.8% (28.7-32.8%) for Vietnamese, 36.9% (35.9-37.8%) for Asian Indians, 
and 38.2% (36.5-39.9%) for Japanese (Powell et al., 2013, p. 10).  These variations in 
cardiovascular risk factors associated with hypertension are obviously modulated by 
race/ethnicity and prevalent comorbidities (Aronow et al., 2011).  
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Evidence suggested that hypertension is highly prevalent among obstructive sleep 
apnea (OSA) patients (Baguet et al., 2006).  Numerous studies have confirmed that the 
intermittent airway occlusion exhibited during nocturnal sleep typical in obstructive sleep 
apnea evoked acute transient increases in nighttime blood pressure which consequently 
produced sustained daytime hypertension (Borgel et al., 2004).  Studies have shown that 
about 30%-40% of hypertensives have some form of OSA (Worsnop et al., 1998).  
Systemic hypertension is also prevalent among an estimated 50%-60% of OSA patients 
(Silverberg et al., 2001).  Additionally, 40% of patients with systemic hypertension have 
undiagnosed OSA (Silverberg et al., 1997). 
In the last few decades, studies throughout the world have led to the recognition 
that the many mechanisms linking hypertension significantly affect the 
pathophysiological mechanisms of OSA (Kapa et al., 2008; Lopez-Jimenez et al., 2008; 
McNicholas et al., 2007; Quan & Gersh, 2004).  Both OSA and hypertension are complex 
disorders modulated by a number of risk factors (Villanueva et al., 2005).  Race is an 
important risk factor in development of OSA and hypertension (Yaggi & Strohl, 2010).  
Asians are contemporarily classified as Asians/ Pacific Islanders in the United States 
(Villanueva et al., 2005, p. 420).  Such national descriptors do not accurately convey 
genetic variation in the prevalence of hypertension among middle aged Asians with OSA.  
Moreover, craniofacial structure is an important and often ignored risk factor among 
Asians (Villanueva et al., 2005, p. 21).  Interethnic comparison in craniofacial 
morphology might be used to explain any variation in risk for OSA-hypertension.  
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The next few sections of Chapter 1 cover the study’s background, problem 
statement, purpose, research questions and hypotheses, theoretical framework, nature, 
definitions, assumptions, scope and delimitations. 
Background 
In the years following early notions concerning whether OSA is an independent 
risk factor for hypertension, numerous large epidemiologic studies provided substantial 
proof that OSA does increase the risk for hypertension (Punjabi, 2008).  The Sleep Heart 
Study, a cross-sectional study of 6,132 patients aged 40 and above, by employing in-
home polysomnography, showed that in a significant number of patients, OSA was 
independently associated with hypertension (Nieto et al., 2000).  The association, 
although quite modest, revealed that adjusted odds ratio for AHI > 30 (versus AHI < 1.5) 
was 1.37 (95% CI 1.03-1.83; Nieto et al., 2000, p. 1832).  The Wisconsin Heart Study, a 
prospective study using in-laboratory polysomnography, also demonstrated that OSA was 
associated with hypertension.  The Wisconsin study also revealed that the adjusted odds 
ratio of OSA (AHI > 30) to hypertension was 3.1 (95% CI 1.7-5.7; Nieto et al., 2000, p. 
1832).  Furthermore, the odds ratio for the development of new onset hypertension 
associated was 2.89 (95% CI 1.46 > 5.64 for AHI >15 versus 0; Peppard et al., 2000).  
However, the interpretations of these epidemiologic studies in relation to Asian 
populations have several limitations.  First, the OSA studies conducted in the past have 
largely described the prevalence of OSA and OSA’s association to hypertension 
predominantly among White populations.  Second, the interpretation of data linking OSA 
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to hypertension should be construed cautiously as minority populations often have 
additional risk factors.  Third, limited studies in the literature have been conducted that 
have specifically investigated racial variations in OSA as an independent risk factor for 
hypertension. 
Given the significant impact of OSA on cardiovascular morbidity and mortality, 
identification of OSA as an independent risk factor for hypertension among the diverse 
susceptible Asian subgroups may lead to physician improvements in the diagnosis, 
treatment, and control of these diseases. Additionally, the results generated from this 
research would lead to the creation of larger epidemiological studies cross sectional 
studies involving this vulnerable population. 
Statement of the Problem 
Obstructive sleep apnea is a major public health issue, with 2-6% of the 
population experiencing severe obstructive sleep apnea (Cantolla et al., 2009; Punjabi, 
2008; Vozoris, 2012).  The current literature indicates that the repeated arousals and 
intermittent hypoxemia associated with obstructive sleep apnea are principal in the 
pathogenesis of hypertension (Guillot et al., 2013; Mohsenin et al., 2009; Ryan et al., 
2013).  The risk of hypertension intensifies with increasing severity of obstructive sleep 
apnea even after adjusting for risk factors like obesity and age (Duran-Cantolla et al., 
2009; Peppard et al., 2000; Sforza & Roche, 2012).  There are no published scientific 
reports on the general prevalence of OSA among Asians. Hui et al., (2006) and Kim et 
al., (2004) estimated that the OSA prevalence rate among Asians was 4%.  In a recent 
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systematic review of the literature, Mirrakhimov et al. (2013) found that among 47,957 
Asian subjects, OSA prevalence were estimated to be about 3.7% to 97.3%.  This 
analysis also showed that the risk factors associated with OSA were male gender, older 
age, higher BMI, higher waist-to-hip ratio, greater neck circumference, arterial 
hypertension, smoking, snoring, and daytime sleepiness (Mirrakhimov et al., 2013, pp.9-
10). 
However, the data are conflicting for these ethnic groups (i.e., Asians; (Genta et 
al., 2008; Ip et al., 2001; Kawaguchi et al., 2011).  The accumulated findings from large 
scale studies of sleep-diagnosed OSA patients, random cohorts of the general population, 
case-controlled, and intervention studies found no consistent evidence of obesity and 
gender differences in the prevalence of obstructive sleep apnea with hypertension among 
Asians (Genta  et al., 2008; Ip  et al., 2001; Mirrahkimov et al., 2013; Villanueva et al., 
2005).  
OSA is an independent risk factor for hypertension (Bixler et al., 2000; 
Kasiakogias et al., 2013; Marin et al., 2012; Nieto et al.,2000; Tsioufis et al., 2011; 
Young et al., 2000).  There are ethnic differences in the prevalence and severity of OSA 
(Villanueva et al., 2005).  Craniofacial features seem to play a role in the differences in 
prevalence and severity among Asians (Duran et al., 2001). 
Santa Clara County has 1.8 million residents, among whom 33.7% are Asians, 
(U.S. Census Data, 2012).  Health disparities exist among Asians in this county, with 
certain subgroups experiencing higher prevalence of risk factors.  There is a significant 
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association of these two diseases in terms of cardiovascular morbidity and mortality.  In 
order to understand the burden of these diseases, there is a need to understand what the 
prevalence of OSA and hypertension among Asians is.  Hence, the purpose of the study 
was to address this gap and to determine the role of other risk factors, such as age, 
gender, smoking, body mass index (BMI), Mallampati score (MS), Epworth Sleepiness 
Scale (ESS), and Apnea-Hypopnea Index (AHI) that influence the prevalence rate of 
OSA and its association with hypertension among middle aged Asians residing in San 
Jose, CA.  
Purpose of the Study 
The main purpose of this quantitative cross-sectional study was to determine: (a) 
the prevalence rate of OSA among middle-aged Asian patients (Chinese, Filipino, 
Vietnamese, Asian Indians, Korean, Taiwanese, Japanese, and Singaporean) in San Jose, 
CA.; (b) the association between OSA and hypertension; and (c) the association of other 
risk factors: age, gender, smoking, body mass index (BMI); Mallampati score (MS), the 
Epworth Sleepiness Scale (ESS) and Apnea-Hypopnea Index (AHI) with hypertension as 
the outcome. 
Research Questions and Hypotheses 
The overarching research question concerned the association of OSA and other 
risk factors as related to hypertension among middle-aged (40-60+ years old) Asians 
living in San Jose, CA.  To answer the above research question, the following 
subquestions were examined. 
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Research Question 1.  What was the association between OSA and hypertension 
among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 1.  There was no association between OSA and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 1.  There was an association between OSA and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 2.  What was the association between age and hypertension 
among a sample of middle aged-Asians living in San Jose, CA? 
Null Hypothesis 2.  There was no association between age and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 2.  There was an association between age and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 3.  What was the association between gender and hypertension 
among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 3.  There was no association between gender and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 3.  There was an association between gender and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 4.  What was the association between smoking status and 
hypertension among a sample of middle-aged Asians living in San Jose, CA? 
8 
 
Null Hypothesis 4.  There was no association between smoking status and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 4.  There was an association between smoking status and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 5.  What was the association between body mass index (BMI) 
and hypertension among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 5.  There was no association between body mass index (BMI) 
and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 5.  There was an association between body mass index 
(BMI) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 6.  What was the association between Mallampati score (MS) 
and hypertension among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 6.  There was no association between Mallampati score (MS) and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 6.  There was an association between Mallampati score 
(MS) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 7.  What was the association between the Epworth Sleepiness 




Null Hypothesis 7.  There was no association between the Epworth Sleepiness 
Scale (ESS) and hypertension among a sample of middle-aged Asians living in San Jose, 
CA. 
Alternative Hypothesis 7.  There was an association between the Epworth 
Sleepiness Scale (ESS) and hypertension among a sample of middle-aged Asians living 
in San Jose, CA. 
Research Question 8.  What was the association between the Apnea-Hypopnea 
Index (AHI) and hypertension among a sample of middle-aged Asians living in San Jose, 
CA? 
Null Hypothesis 8.  There was no association between the Apnea-Hypopnea Index 
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 8.  There was an association between the Apnea-
Hypopnea Index (AHI) and hypertension among a sample of middle-aged Asians living 
in San Jose, CA. 
The analysis determined the association between OSA, age, gender, smoking 
status, body mass index, Mallampati score, the Epworth Sleepiness Scale, and Apnea-
Hypopnea Index to hypertension.  Means, standard deviation, and frequency of 
distribution were calculated for continuous independent variables such as age, gender, 




The theoretical guide for this study was the sufficient component causes model.  
This model, which, emerged in the epidemiological literature in 1976, described the 
many contributing determinants, and risk factors that make up the multifactorial 
etiologies involved in the association between OSA, and hypertension among middle-
aged Asian patients. 
The sufficient component causes model, pioneered by Rothman (1976), is an 
epidemiological model that defines a sufficient cause as “a complete causal mechanism” 
that eventually leads to the development of a disease (Flanders et al., 2006; VanderWeele 
et al., 2006).  This model considers the development of a disease either through a 
complete causal mechanism, or through a minimum set of conditions or factors, that, if 
present in a given individual, will be sufficient for the outcome to ensue (Rothman et al., 
2008).  
According to the major proponents of this model, health conditions are outcomes 
of complex component interrelationships of various predisposing factors that must be 
present or have occurred for the disease to manifest (Rothman et al., 2008, pp. 6-8).  The 
sufficient cause component model seeks to identify the possible set of conditions critical 
to the development of illness by recognizing the constellation of component causes of 
conditions, factors causing the condition(s), and factors that act in unification to cause the 
condition (Rothman et al., 2008, pp. 7-8).  The sufficient component cause model is 
characterized by a number of features; for instance, a cause not single but consists of a 
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minimal set of conditions or events, each component in a sufficient cause is called a 
component cause, and there is no need to identify all of the component causes to prevent 
the disease outcome (Aschengrau & Seage, 2008).  This component cause together 
constitute a sufficient cause for the outcome in question.  In order to fully understand all 
the risk factors, exposure, and contributory causes of the disease, the model requires 
complete understanding or investigation of the diseases (Timmreck, 2006, p. 209). 
The sufficient component cause theory guided this study and made it possible to 
describe the association between OSA and hypertension among middle-aged Asians in 
the United States.  Studies have shown that the independent association of OSA to 
hypertension is affected by the increased sympathetic activity in response to hypoxemia 
and hypercapnia that lead to chemo reflex activation, which increase the peripheral 
vascular tone (Phillips & Somers, 2003).  This sympathetic response continues even into 
daytime normoxia (Phillips & Somers, 2003, p. 381).  Chemoreceptors, both peripheral 
and central, are inhibited, leading to decreased ability to breathe (Sadikot, 2008).  The 
subsequent hypoxemia can stimulate the augmented production of many circulating 
vasoconstrictors that raise blood pressure (Phillips & Somers, 2003, p. 382).  The 
consistent cycles of increased sympathetic stimulation, renin-angiotensin system, 
endothelial dysfunction, cerebral blood flow alterations, oxidative stress, and systemic 
inflammation also contribute to an increase in heart rate and blood pressure.  The 
presence of risk factors (e.g., obesity; craniofacial morphology) in sleep apnea likely 
indicates an increased susceptibility to hypertension (Phillips & Somers, 2003, p. 383). 
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The key constructs of this model supported the belief that component causes or 
risk factors (e.g., body mass index (BMI), Mallampati score (MS), Epworth Sleepiness 
Scale (ESS), and apnea-hypopnea index (AHI) together constitute a sufficient cause 
model for the OSA-hypertension association. The table below shows how these risk 
factors are associated with certain causes of OSA as an independent predictor of 
hypertension as guided by the sufficient component cause theory. 
Table 1 
OSA Risk Factors as Guided by the Sufficient Component Cause Theory 
Causes Risk factors Measurement 
Sympathetic stimulation Apnea/and/ or hypopnea AHI index/Epworth Sleepiness Scale 





Cerebral blood flow alterations Craniofacial features, gender Mallampati score 
Note Adapted from “Epidemiology and The Web of Causation: Has Anyone Seen The 
Spider? by N. Krieger, 1994. Social Science Medicine, 39(7), pp 887-903. 
 
Detailed discussion of the model will be discussed in the next chapter. 
Nature of the Study 
I employed a quantitative cross-sectional study to determine the relationship 
between OSA as an independent variable and hypertension as the outcome among 
middle-aged Asian patients.  The advantage of using this type of study was that it allowed 
me to examine the associations between variables within a short period of time based on 
biological plausibility and past research (Newman et al., 2007).  The main variables that 
the study assessed were obstructive sleep apnea, as the independent variable and 
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hypertension as the dependent variable.  Other risk factors including age, gender, 
smoking, OSA severity (measured by apnea-hypopnea index [AHI]), body mass index 
(BMI), daytime sleepiness (measured by Epworth Sleepiness Scale [ESS]), and 
craniofacial characteristics (measured by Mallampati score [MS] were assessed for their 
role in the development of hypertension as the outcome in association with OSA using 
ANOVA.  
Three sleep study clinics were used to assess the participants who partook in an 
overnight polysomnography in a real life sleep clinic in San Jose, CA.  The study 
variables and other demographical information including age, sex, history of smoking, etc 
were collected and analyzed using paper and electronic medical records. 
Definition of Terms 
Apnea is the absence of airflow for 10 seconds in the presence of continued 
respiratory effort (Hahn & Somers, 2007, p. 943).  
Apnea-hypopnea index (AHI) is the total number of apneas and hypopneas 
divided by the total number of hours of sleep (Banno et al., 2007, p.402).  
Asians refer to the group of people living in Asia. The Behavioral Risk Factor and 
Surveillance system categorizes this group into seven groups; namely, Asian Indian, 
Filipino, Chinese, Vietnamese, Korean, Japanese and other Asians (Palanaippan et al., 
2010).  
Body mass index is a reliable measure to determine body fat for individuals. It is 
calculated based on a person’s weight and height.  
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Hypertension also called high blood pressure, is based on the measured force of 
blood against the walls of the arteries as the heart pumps blood to the body (Victor, 
2011).  
Hypopnea is a reduction in airflow ≥ 50% for 10 seconds with 4% drop in arousal 
and saturation (Hahn & Somers, 2007, p. 943).  Hypopnea is clinically significant when 
associated with an oxyhemoglobin desaturation event or with a central nervous system 
arousal characterized by EEG changes or alpha activity (Hirskowitz & Kryger, 2005).  
Epworth Sleepiness Scale is a scale to measure daytime sleepiness by using a 
questionnaire. A score of 10 or more is considered sleepy.  
Mallampati score is a grading scale to assess the tonsil and visibility of the 
tonsillar fossa. Class 1 shows that the entire tonsil is visible, Class 2 shows that only half 
of the tonsil fossa is visible, Class 3 shows clear visibility of the soft and hard palate and 
Class 4 shows only the hard palate (Mallampati et al., 1985). 
Obstructive sleep apnea syndrome (OSAS) is clinically defined as AHI ≥ 5 per 
hour with symptoms or more than 15 without symptoms (Hahn & Somers, 2007, p. 943).  
This condition is characterized by breathing cessation caused by obstruction of the upper 
airway (Hirskowitz & Kryger, 2005).  
Oxygen desaturation index (ODI) is the number of oxyhemoglobin desaturation 
events per hour of sleep (Hirskowitz & Kryger, 2005).  
Polysomnography (PSG) is the method used to consistently measure nasal 
pressure, oxygen saturation, electroencephalogram, electro-oculogram, chin and lower 
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extremity electrocardiogram, chest, and abdomen plethysmography (Hahn & Somers, 
2007, p. 943). 
Assumptions 
The basic assumption of this study was that it was conducted among study 
subjects who had consented to participate voluntarily.  Due to the voluntary nature of this 
study, it is hoped that the results were not influenced by a high degree of bias.  The study 
used secondary data obtained from sleep clinics in San Jose, CA.  Walden University 
Institutional Review Board with approval number 03-25-14-0153639 approved the use of 
secondary data from three sleep study clinics in San Jose, CA.  The adoption of 
secondary data presents an opportunity to develop primary data in future research.  It is 
also assumed that the sleep metrics used, including AHI, polysomnograms, and other 
metrics, were suitable to measure the study variables.  
The secondary data i.e., electronic medical records system used in this study 
represented real world data that reflected fairly accurately actual physician practice 
compared to observational data (Dean et al., 2009).  It was assumed that the respondents 
were accurately diagnosed according to symptoms and clinical presentations.  It was also 
assumed that participants’ gender did not significantly affect physicians and other allied 
health professionals diagnosis of the conditions.  
I also assumed that craniofacial features influenced the relationship between OSA 
and hypertension.  The craniofacial abnormality subjects the pharynx to be a risk of 
airway closure independent of soft tissue influences.  The Mallampati Scoring System as 
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marker for craniofacial abnormality was scored typically by physicians who were 
assumed to be able to identify the four anatomical landmarks in the oropharyngeal region. 
Scope and Delimitations 
This study was about the prevalence rate of OSA as an independent variable in 
association with hypertension as an outcome among middle aged Asians.  Due to the 
large number of potential participants in the study population, the study only focused on a 
sample of 462 Asians in three sleep study clinics located in San Jose, CA during the 
period from January 1, 2008 to December 31, 2011.  The generalizability of this 
epidemiological study may be limited to certain Asian Americans living in San Jose, CA 
and may not be representative of the United States, as a whole.  It is known that diseases, 
regardless of etiology, are affected by multifactorial causes.  As the study focused only 
on OSA and hypertension as the outcome, the study is most relevant in this particular 
area.  The data and results of the study were derived from electronic and paper medical 
records, in which study participation among the subjects and the medical practitioner 
were assumed to be voluntary.  Thus, the study was subjected to inherent limitations of 
such methods, including biases related to patient population, selection and reporting.  The 
potential biases related to patient population, selection, and reporting were reduced by 
randomly sampling patient population within three sleep clinics used in this study.  The 
potential bias was also eliminated by obtaining the appropriate number of patients to 
power the study, judiciously designing the study, guaranteeing that sample methods were 
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reliable, and employing procedures using standardized methods to accurately measure the 
data collected (Peat & Mellis, 2002). 
Limitations 
A limitation of this study was that the sample was drawn from Santa Clara County 
only.  This affects the generalizability of the study to the other counties.  In order to 
address this issue, the study used the correct t-value for alpha which is 0.05.  The study 
employed data obtained from electronic medical records (EMR) and paper medical 
records which were basically designed for clinical care and not research.  EMR provide 
the researchers with easy access to patient data, large cohorts, patient-level diagnoses, 
treatment data, and billing, and laboratory information.  However, limitations in the use 
of EMR include information entered being decided by the provider, information entered 
in free text, scanned images, flexibility in terminology, a minimal number of required 
fields, and important data irrelevant to clinical care is missing (Terry et al., 2010).  
Another limitation of the use of secondary data is the lack of clinical detail (Gallin & 
Ognibene, 2012).  This is especially true because certain EMR data sets will contain 
clinical data relevant to physician payments (Gallin & Ognibene, 2012, p. 375). Another 
limitation of the study was the inability of the researcher to provide the temporal 
sequence of the exposure and the outcome (Ho et al., 2008).  In order to assure that the 
tools for the analysis and data generated were valid and reliable, I checked for bias, and 
cross checked the data looking at both paper and electronic records if both were available 
(Babbie, 2010).  Validity issues in this study might stem from bias in data collection, 
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subject selection, and inadequate procedures (Creswell, 2009).  In order to address these 
issues, I validated the codes used by the practitioners by confirming with the current 
International Classification of Diseases Manual, randomly sampling patients in the study 
sleep study clinics chosen for the study, and setting inclusion and exclusion criteria for 
patient selection.  To validate the research findings, I looked at existing literature to 
confirm which specific variables would throw light on the relationship between the 
variables and covariables (to determine the accuracy of findings), and construct validity 
(if the theoretical model applied well in this study) (Creswell, 2009, pp. 149- 190).  
The limitations associated with this data analysis also included variation in 
software platforms used by the clinics for their EMR systems, medical terminology, 
clinical data, (i.e., laboratory results), and units of measurement (Dean et al., 2009).  In 
order to address these issues, the researcher ensured that standardized coding practices 
were adopted at each clinic, similar medical terminologies were used; and laboratory 
results were reported in the same units of measurement (Dean et al., 2009, p. 613). 
Significance 
There are very limited published scientific data on the general prevalence of OSA 
among Asians.  This study uniquely addressed an important public health issue among a 
segment of the population that has significantly grown in number in the San Jose, CA 
area for the last few years.  This study was able to provide much needed data on the 
prevalence of OSA and the associated risk factors between OSA and hypertension.  The 
valuable insights that may be acquired from this study could pave the way for additional 
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scientific pursuits that could lead to better understanding of OSA and hypertension 
among middle aged Asians.  
This study also adds to the epidemiologic understanding of OSA as the 
independent variable and hypertension as an outcome among middle-aged Asians in San 
Jose, CA.  OSA-hypertension research studies conducted among high risk Asian groups 
can generate valuable public health insight into the disease and its risk factors.  This is 
critically important especially when studies involving OSA do not adequately synthesize 
or provide clarity regarding the health differences among Asian Americans.  Because 
there are still a great number of underdiagnosed and undertreated Asian patients in San 
Jose, CA, the results generated from this research can lead to successful identification, 
screening, treatment, and management of OSA and hypertension especially among high- 
risks middle-aged Asians, thus creating positive social change for those individuals and 
their families and community.  This study can also foster social change by empowering 
members this ethnic group to advocate for themselves and collectively challenge service 
providers, government agencies, and other institutions to ensure equal access to 
healthcare, and available services.  Additionally, this study may create positive social 
change by fostering improvements in health outcomes and the lives of Asians who have 
been suffering from OSA and hypertension for a long time. 
Summary 
The prevalence of OSA and hypertension in the United States continues to rise.  
The various structural and functional cardiac dysfunctions associated with OSA have 
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important pathologic consequences to the development of hypertension.  Numerous 
observational and epidemiologic studies have been designed to better understand the 
association of OSA and hypertension and the consequences they have for CVD among 
Caucasian patients. OSA data among Asians are very limited.  
Hypertension outcomes associated with OSA have been measured by 
polysomnography specifically using the Apnea-Hypopnea Index (AHI) as a common 
metric.  Body mass indexes (BMI), Mallampati scores (MS), and the Epworth Sleepiness 
Scale (ESS) are also common metrics used in OSA studies. 
Research efforts in the field of sleep apnea have provided intense and consistent 
results linking OSA to hypertension.  The epidemiologic data from various human 
populations that are consistent with the mechanistic theory that supported the study are 
summarized in the next chapter. 
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Chapter 2: Literature Review 
The literature review provided the basis for the need to examine the prevalence 
rate of OSA and its association to hypertension among middle aged Asian patients.  In the 
last three decades, investigations have shown significant linkages between OSA and 
hypertension, as well as their important implications on long term effects on 
cardiovascular morbidity and mortality.  Mechanistic, animal, human interventional and 
epidemiological studies have revealed that systematic changes in blood pressure in OSA 
together with the presence of significant confounders are major contributors to the 
development of hypertension.  Although this association between OSA and hypertension 
had been reported in the literature, systematic investigations to address the question of 
whether similar associations are seen among Asians have rarely occurred.  The unique 
craniofacial anatomic features among Asians may be the delineating difference (e.g., 
retrognathia) that can predispose Asians to develop OSA leading to hypertension.  The 
theoretical foundation that guided this dissertation was the sufficient component cause 
model.  This sufficient component cause model may be used to describe the association 
of OSA and hypertension as these diseases are highly associated with a number of 
significant risk factors (Dopp et al., 2007; Stehbens, 1985).  The associated risk factors 
are significantly associated with the development of the disease, and if these risk factors 
are modified by intervention, it reduces the occurrence of the disease.  The complete 
airway obstruction experienced during sleep leads to apnea or cessation of breathing, 
whereas the experienced caused by partial airway obstruction leads to hypopnea and 
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elevated PCO2, (Banno & Kryger, 2007, p. 401).  A recent review of the literature 
showed that this theoretical construct provided a clear view of how these various risk 
factors work together to impact the OSA and the development of hypertension among 
middle-aged patients  (Bixler et al., 2001; Bixler et al., 1998; Duran et al., 2001, Ip et al., 
2001, Peppard et al., 2000; Young et al., 2002).  
The empirical basis of this research is supported by peer-reviewed journals.  The 
search for relevant articles to support the aforementioned evidence was made using 
medical search terms, subject headings, reference lists, key words and “related articles” 
links using MEDLINE, PUBMED, Medscape, CDC, NIH, Science, and Walden 
University library databases.  The search terms to obtain these scientific articles included 
obstructive sleep apnea, hypertension, sufficient component cause model, sympathetic 
activation, apnea cardiovascular adverse effects, age, craniofacial characteristics, AHI 
index, obesity, ethnicity sleep apnea, multicausation, hypertension risk factors, 
hypertension trends, OSA risk factors, Asians, and Asian Americans.  Sources to support 
this dissertation were obtained either in digital format or as traditional printed versions of 
scientific articles.  The search of these articles was limited to those published between 
1995 and 2012 and written in English.  The articles chosen were from epidemiologic 
research.  This dissertation was also supported with multiple books to provide years of 
scientific research on obstructive sleep apnea and hypertension.  
This chapter provided a review of OSA, hypertension, relevant theoretical 
constructs, and the pathophysiologic evidence to support OSA’s linkage to hypertension.  
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The chapter also provides systemic epidemiologic review of the literature to support the 
contributory role of OSA to hypertension.  This chapter also contains a discussion of the 
current challenges of the outcomes of these research areas. 
Obstructive Sleep Apnea: Introduction 
The majority of cases of hypertension have unknown causes, whether 
hypertension could be considered primary or essential (Kaplan, 2011).  Additionally, the 
severity of hypertension is largely determined by specific demographic features (age, sex, 
race, etc.), the magnitude of vascular damage from high blood pressure, and the presence 
of other risk factors (Kaplan, 2011, p. 15).  The complicated etiology and 
pathophysiology of hypertension emanate from the heterogeneous nature of the disease 
(Izzo & Black, 2003).  Multiplicative factors modulate blood pressure control (Heilperm, 
2008).  Epidemiologic studies have revealed that OSA in combination with other CV risk 
factors is associated with hypertension, which predispose patients to the risk of both 
cerebrovascular and ischemic heart disease (U.S Department of Health and Human 
Services, 2004, p. 1).  The effective management of hypertension has been associated 
with considerable improvements in aged-adjusted death rates from stroke and heart 
disease irrespective of gender, age, race or socioeconomic status (U.S. Department of 
Health and Human, 2004, p. 1).  However, follow-up studies conducted with multiple 
populations have indicated that morbidity and mortality rates are higher among patients 
receiving antihypertensive drug treatments compared to untreated patients with similar 
levels of blood pressure (Ben-Dov et al., 2007).  These studies indicate that modest CVD 
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improvements could be due to: partial reduction in blood pressure, irreversible organ 
damage from hypertension, and other risk factors not properly addressed (Kaplan, 2011, 
p. 8).  The strategic management of hypertension comes with knowledge of evaluation of 
other important risk factors. Clustering of this hypertension associated risk factors occurs 
approximately 50% of the time (Caceres et al., 2012).  Identification of these associated 
risk factors can lessen the degree of coronary events, stroke, peripheral disease, or heart 
failure (Kaplan, 2011, p. 10).  The numerous pathological mechanisms involve with OSA 
increase the risk of hypertension (Calhoun & Harding, 2010).  Peppard et al., (2001) 
showed that even after adjustment of known risk factors for hypertension, there was a 
twofold risk increase for patients with AHI of 5-15/ hour and threefold increase for 
patients with AHI > 15 (Peppard et al., 2000, p. 1378). 
Definitions: Obstructive Sleep Apnea and Hypertension 
Diagnosis of hypertension, defined as blood pressure of 140mmHg/80 mmHg, is 
often challenge by the fact that considerable variability in measurements occurs (Kaplan, 
2011).  Sources of variation include inappropriate equipment, inaccurate reading, 
incorrect positioning of the arm, and observer bias (Kaplan, 2011, p. 25). Chang et al., 
(2002) reported 64-82% residual variability with systolic and diastolic measurements 
from inaccuracy of the device.  In order to establish accuracy for in home, in office or in 
clinical studies, patients are advised to prevent marked changes induced by activity and 
position, keep a diary of activities, use computer-assisted diaries, use electronic monitors 
and obtain average values within the 24 hours (Kaplan, 2011, p. 39).  
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It is important to establish the clinical definition of OSA in order to fully 
comprehend the key differences between the sensitivity, specificity and predictive value 
of the various diagnostic techniques used in various studies (Frederick & George, 1999, 
p. 356).  Guilleminault & Dement (1976) defined OSA as cessation of airflow for 10 
seconds with 30 apneic events observed in both REM and NREM sleep observed during 
seven hours of sleep study (Frederick & George, 1999, p. 357).  The diagnosis of OSA is 
confirmed by Apnea-Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) ≥ 5 
events /hour during a polysomnography with monitored respiratory parameters (Kushida, 
et al., 1997).  OSA is a chronic condition involving a characteristic closure of the airway 
at the supraglottic area (Mansfield & Naughton, 2005).  This effect converges at the 
apnea termination, which causes the recurrent brief arousals throughout the night 
(Mansfield & Naughton, 2005, p. S2).  OSAs are associated with variable drop in arterial 
oxygen saturation (SAO2) of various intensities (Mansfield & Naughton, 2005, p. S2).  
The International Classification of Sleep Disorders, 2nd edition, categorically diagnoses 
OSA as follows: 
A. At least one of the following: 
• complaints of unintentional sleep episodes during wakefulness, daytime 
sleepiness, unrefreshing sleep, fatigue or insomnia; 
• awakenings with breath holding, gasping, or choking; 




B. Polysomnography with the following results: 
• scoreable respiratory events (apneas + hypopneas + Respiratory Effort –
Related Arousals (RERA)/hr. of sleep ≥ 5/hr.); 
• evidence of respiratory effort during all or a portion of each respiratory 
event (In the case of RERAs, respiratory effort is best detected by 
esophageal manometry); or  
C. Polysomnography with the following: 
• score able respiratory events (apneas+hypopneas+RERAs)/hr. of sleep ≥ 
15/hr; 
• evidence of respiratory effort during all or a portion of each respiratory 
event; 
D. The disorder is not better explained by another current sleep disorder, medical 
or neurologic disorder, medication use, or substance use disorder (American 
Academy of Sleep Medicine, 2001).  
The American Academy of Sleep Medicine defined OSA based on RERAs but 
not RDI (number of respiratory events per hour of monitoring time).  The majority of 
sleep studies use RDI instead of RERA.  However, most of the literature do use the OSA 
diagnostic criteria of AHI ≥ 5/hr. with symptoms or AHI ≥ 15/hr. with or without 
symptoms (Bradley & Floras, 2009).  The ICD definitions do not include partial 
obstruction or complete obstruction to diagnose OSA.  
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The Practice Parameters of the American Academy of Sleep Medicine established 
a consensus statement in 1997 the evidence based recommendations for the diagnosis and 
management of OSA.  Based on this evidence based guideline, the diagnosis of OSA 
must be established with sleep history, physical examination, and standard sleep testing 
(in laboratory polysomnography (PSG), or home testing with portable monitors (PM; 
Epstein et al., p. 266, 2009).  PSG is routine test for clinical diagnosis and indicated for 
patients with high pretest likelihood of moderate to severe OSA (i.e., obese, heart failure, 
coronary artery disease, history of transient ischemic stroke, or significant arrhythmias 
(Epstein et al., 2009, p. 266). Diagnosis should be obtained in one of three settings: 1.as 
routine health maintenance evaluation; 2. as part of evaluation for patients with 
symptoms of OSA; and 3. as part of comprehensive evaluation of patients’ high risk for 
OSA (Epstein et al., 2009, p. 264).  The important features that are clinically relevant in 
the diagnosis for OSA includes increased neck circumference (>17 inches for men and 16 
inches for women), body mass index (BMI > 30 kg/m2), modified Mallampati score of 
three or four, presence of retrognathia, lateral peritonsillar narrowing, macroglossia, 
tonsillar hypertrophy, elongated/enlarged uvula, high arched/narrow hard palate, nasal 
abnormalities, and/or over-jet (Epstein et. al., 2009, p. 266). 
OSA and Hypertension: Theoretical Constructs 
Rothman (1976) recognizing that the occurrences of certain diseases were caused 
by multiple causes, in which no single factor can produce the disease itself, proposed a 
model that he termed a “sufficient component cause model”.  According to Rothman 
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(1976) a “cause” is a state of nature, act, or event that leads, or allows either by itself, or 
combination with other causes, a succession of events that will lead to an “effect” (Rao & 
Enterline, 1983).  The “sufficient component cause model” represented the cause that 
would be estimative to produce the outcome as “sufficient” (Rao & Entreline, 1983, p. 
268).  Thus, Rothman (1976) believed that a sufficient cause is an amalgamation of 
condition that consequently would lead to the outcome in consideration (Rao & Enterline, 
1983, p. 267).  According to this model, a number of component causes make up the 
sufficient cause, which will operate sufficiently enough under various sets of component 
causes to act as “sufficient cause” (Martin, 2008).  In other words, the sufficient 
component cause model embodies biologic relations in the form of involvement of 
factors in a sufficient cause (Vanderweele, 2009).  
The term “causation” refers to the relationship between at the least two entities: 
the agent and the disease (Vineis & Kriebel, 2006).  The sufficient component cause 
theory does not imply that there is a specific cause for a given disease in a given 
individual but rather the disease is smartly intertwined with multiple intersections which 
determines the association between given exposure and frequency of disease in a given 
population (Vineis & Kriebel, 2006).  The associations can indicate that the exposure 
might cause the disease or the exposures are associated with difference in “risk factors” 
(Krieger, 1994).  
According to this model, sufficient cause refers to “a set of minimal conditions 
and events” not necessarily gratuitous, that leads to the production of the disease (Allard 
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& Boivin, 1993).  The components of each the conditions which are part of the sufficient 
cause, which will be called a “component” of the cause (Allard & Boivin, 1993, p. 37).  
The assemblage of the components of the disease would then lead to the development of 
the disease (Allard & Boivin, 1993, p. 37).  Sufficient causes are basically disease 
producing process, in which the accumulation of the components would be sufficient 
enough for the expression of the disease (Allard & Boivin, 1993, p. 37).  
Rothman (1976) further refined the sufficient component cause theory to take into 
account confounding and effect modification to pay attention to the relationships between 
“necessary and component causes”.  Rothman developed the sufficient component cause 
model which incorporated the “sufficient causal complexes, with five component causes” 
later termed as “causal pie model”.  By bringing attention to these factors, Rothman was 
able to show that the strength of the association between the component cause and 
outcome depended on the prevalence of other components that influenced the specified 
change (Krieger, 1994, p. 891).  Additionally, this concept explained that diseases were 
caused by mixtures of conditions or multiple conditions that together contributed to the 
development of the disease, and that various combinations of component causes can 
produce the disease; and that the multiple causes need not include any component cause 
in common (Labarthe, 2011, p. 541).  
Aschengrau and Seage (2003) outlined that the basic features of the sufficient 
component cause model are as follows: 
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1. There is no single cause for the disease but a minimal set of 
conditions or events that would lead to the development of the outcome. 
2.  Each of the component causes is important in the sufficient 
component cause model; however, it is not necessary to identify all of the 
component causes in order to avert the disease. 
3.  There could be a number of sufficient cause for a given disease or 
outcome. 
4. A component cause that must be existent in every sufficient cause 
of a given outcome is termed “necessary cause”.  
5.  The biologic occurrence of the outcome must parallel with the 
completion of a sufficient cause. 
6. The components of the sufficient cause can act at different times 
and not necessarily concurrently. 
The sufficient component cause model can help explain the theoretical structure 
of sufficient causes for OSA and hypertension.  A sufficient cause can be interpreted in 
this case as if the risk factor for hypertension is present, then the presence of that risk 
factor, in this case OSA,  leads to the increase risk of the disease.  Additionally, the 
relationship between OSA and hypertension is an example of a chronic disease caused by 
an array of sources and risk factors.  The association between hypertension and OSA is 
multifactorial, with a number of unique overlapping causal mechanisms (Punjabi, 2008).  
The source of interaction between component causes in the sufficient component cause 
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model as proposed by Rothman (1976) is the combined involvement of the component 
causes in a sufficient cause (Rao & Enterline, 1983).  This theoretical construct supports 
the idea that OSA involves grouping of one or more of the sufficient causes and the factor 
that is part of more than one sufficient cause (Martin, 2008).  The components of a 
sufficient cause can be simultaneous, or can be represented by a chain of events, in which 
one of the components can lead to another (Martin, 2008, p. 274).  The physiologic 
changes allied with OSA bring a plethora of various changes that contributes to the 
etiopathogenic mechanism of hypertension, of which a single component cause may be 
insufficient to root the given disease (Cantolla-Duran et al., 2009).  Studies have shown 
that the multitude of events and sources involved with OSA that lead to the changes in 
hypertension physiology are; the negative intrathoracic pressure, sympathetic activation, 
effects of hypoxia, oxidative stress, vascular endothelial dysfunction, metabolic, and 
dysregulation and inflammation. 
Negative Intrathoracic Pressure 
In OSA, the negative intrathoracic pressures generated are from the inspiration 
against a closed upper airway (Adegunsoye & Ramachandran, 2012).  This results to 
negative intrathoracic pressure as low as -80cm H20, which affects both left and right 
ventricular function (Adegunsoye & Ramachandran, 2012, p. 4).  Numerous studies 
showed that negative intrathoracic pressure lead to adverse consequence to left 
ventricular function thru elevating left ventricular transmural pressures and increasing 
afterload (Buda et al., 1979; Virolainen et al., 1995). 
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Sympathetic Activation and Hypoxia 
In OSA, the arterial PCO2 is increased with the rise in arterial PO2 and SaO2 
decrease which permitted the rise of the chemical drives (Cheng et al., 2010).  As the 
total ventilator drive is greater than the arousal threshold, the arousal is generated to 
allow opening of the upper airway to resume airflow (Cheng et al., 2010, p. 6).  The 
arousal threshold is linearly related to SWA.  The higher the threshold, the higher the 
SWA, and closer to one during NREM sleep, while when the threshold is lower, the 
lower SWA or closer to zero during REM sleep (Berry & Gleeson, 1997).  During regular 
sleep cycles, cardiorespiratory homeostasis is achieved through the coordination of both 
the respiratory and cardiovascular system (Khoo et al., 2011).  The cardiorespiratory 
control mechanisms are direct consequences of variations in brain states that typically 
transpired during alternating cycles of NREM and REM sleep (Verrier et al., 2005).  The 
CNS activations dynamically fluctuate to affect heart rate, blood flow, and ventilation 
(Verrier et al., 2005, p. 193).  REM-induced surges facilitate the activation of 
sympathetic and parasympathetic nerve activity causing the surges and pauses in heart 
rhythm (Verrier et al., 2005, p. 193).  In NREM stage, the coupling of the respiratory 
activity and cardiorespiratory centers resulted to the normalization of respiratory sinus 
arrhythmia, (Verrier et al., 2005, p. 193).  NREM stage allowed stable sympathetic 
activity (Verrier, et al., 2005, p. 193).  The cardiorespiratory homeostasis achieved during 
sleep is often altered among OSA patients.  The mitigating effects of repeated arousals 
and intermittent hypoxia characteristic of OSA lead to restructuring of the control 
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mechanisms (Verrier et al., 2005, p. 194).  These types of changes lead to interference in 
compensatory mechanisms to assist blood pressure management and remove forebrain 
influences on hypotension or hypertension (Verrier et al., 2005, p. 194). 
Hypoxia is also an important intermediate mechanism that increased the 
development of hypertension among OSA patients (Leung et al., 2012).  These 
pathological effects acutely lead to hemodynamic and autonomic changes that alternate 
between the apneic and ventilator phases (Leung et al., 2012, p. 221).  Heart rate and 
blood pressure increase happens five to seven seconds after the apneic termination 
(Leung et al., 2012, p. 221).  The OSA related sleep arousal accordingly leads to peak in 
respiration with the pits of SaO2 (Leung et al., 2012, p. 221).  The hypoxia experienced 
during OSA contributes to reduction in myocardial oxygen demand, depression of the 
myocardial contractility, and elevation of left ventricular afterload (Leung et al., 2012, p. 
221).  The sympathetic activation caused the hypoxia driven events which increased heart 
rate (Leung et al., 2012, p. 221).  The relationship between these intermediates is shown 
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Figure 1.  Theory of sufficient component cause model.  The sufficient component cause 
model helps explain the relationship between the unique overlapping causal mechanisms 
that can lead o or affect the pathophysiologic changes involved in the relationship 
between OSA and hypertension. Adapted from “Obstructive sleep apnea/hypopnea and 
systemic hypertension” by Cantolla et al., 2009, Sleep Medicine Reviews.13, pp.323-331 
 
The distinctive respiratory disturbance associated with OSA is the complete 
cessation of breathing that leads to apnea or partial cessation of breathing that led to 
hypoventilation (Krieger, 2005).  This disturbance has three pathophysiologic 
consequences: 1. hypoxemia-reoxygenation leading to arterial blood gas abnormalities; 2. 
consistent arousals and transformation to light sleep stages; and 3. large dips in 
intrathoracic pressure (Krieger, 2005, p. 237).  
All these pathologic disturbances cause increase in sympathetic neural response.  
The sympathetic activation originated from the characteristic apneic events associated 
with OSA which lead to escalation of breathing, high negative intrathoracic pressure, 
persistent hypoxia, reoxygenation, and oscillations in autonomic activity (Krieger, 2005, 
p.238).  The pronounced and severe apneic events eventually impact the hemodynamic 
reflex changes and sustained sympathetic activation (Krieger et al., 2005, p. 238).  The 
elevation in sympathetic response causes activation of vascular smooth muscle to 
vasoconstriction which eventually leads to elevation of blood pressure (Fletcher et al., 
2002).  These heightened sympathetic activities stimulate production of angiotensin II, 
and renin in the kidneys (Fletcher et al., 2002. p. 627).  The sustained sympathoexcitation 
as the likely mechanism of the OSA-hypertension relationship had been observed among 




The marked oxidative stress associated with OSA comes from the marked 
decreased in arterial oxygen saturation (Adegunsoye & Ramachandran, 2011, p. 5).  The 
arterial oxygen desaturation causes similar effects brought about by recurrent episodes of 
ischemia-reperfusion injury (Yamauchi et al., 2005).  This type of injury causes damage 
to the heart attributed to production of reactive oxygen species (ROS) during 
reoxygenation (Yamauchi et al., 2005, p. 1674).  A number of studies had shown that 
oxidative stress associated with OSA, including increases in ROC production were seen 
among OSA patients (Dyugovskaya et. al., 2002; Schulz et. al., 2000).  Yamauchi et al., 
(2005) similarly showed that urinary 8-OHdG excretion, a marker of oxidative stress, 
were higher among OSA patients. 
Vascular Endothelial Dysfunction 
Repetitive hypoxia associated OSA syndrome can lead to vascular endothelial 
dysfunction, (Ip et al., 2004; Ip et al., 2000).  This effect is caused by reduction in 
endothelial nitric oxide production at the transcriptional and posttranscriptional levels as 
well as the rise of reactive oxygen species (ROS; Liao, et al., 1995; McQuillan, et al., 
1994).  The increased production of ROS causes oxidative stress, destabilization of eNOS 
messenger RNA to limit production of cofactors necessary for NO production (Laursen et 
al., 2001; Takemoto et al., 2002).  The short and long term effects of this oxidative stress 
lead to decline in eNOS activity thru subdual of phosphorylation (Takemoto et al., 2002, 
p.57).  This reduction in NO production affects OSA patients to develop vascular 
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diseases, (Takemoto et al., 2002, p. 60).  The repetitive arousals commonly associated 
with OSA also lead to endothelial damage (Atkenson et al., 2009).  The Nurses’ Health 
Study involving 71, 617  female participants aged 45-65 years showed that self-reported 
sleep reduction was associated with increased incidence of coronary heart disease (993 
coronary events;  Ayas et al., 2003).  The study participants who had  fewer than five, six, 
or seven hours of sleep reported age adjusted relative risks of coronary heart disease of  
1.82 [1.34-2.41], 1.30 [1.08-1.57], and 1.06 [0.89-1.26] 95% Cis ( Ayas et al., 2003, p. 
205). 
Metabolic Dysregulation 
Metabolic dysregulation plays a pivotal role in the association between OSA and 
various cardiovascular diseases (Butt et al., 2010).  The main drivers that impact the 
associated role of these factors are also driven by elevated sympathetic activity, changes 
in neuroendocrine function, and release of proinflammatory cytokines (e.g. interleukin-6, 
tumor necrosis factor, and adipocyte derived factors (Aurora & Punjabi, 2007).  Five 
observational studies that looked at patients aged 40-75 years of age with symptoms of 
snoring or apneas were associated independently with increase in glucose, insulin 
resistance, or increase in risk for incident diabetes (Al-Delaimy et al., 2002; Elmasry et 
al., 2000; Enright et al., 1996; Grunstein et al., 1995; Jennum et al., 1993). 
Inflammation 
There are various markers of inflammation that posed as significant risk factors 
for cardiovascular disease that are associated with OSA (Nadeem et al., 2013).  These 
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markers of inflammation include tumor necrosis factor alpha (TNF-), acute phase factor 
C-reactive protein (CRP), interleukin 6 (IL-6), etc. (Gozal & Gozal, 2008).  These 
inflammatory markers acutely affect cardiac function leading to alterations in cardiac 
function such as hypertension and atrial fibrillation (Almendros et al., 2011).  Oxidation 
of low density lipoprotein (LDL) due to endothelial injury had been observed among 
hypoxic OSA patients compared to normal controls (Walli, et al., 1998).  Additionally, 
Carlson et al., (1993) significantly observed that among OSA patients there were more 
vessel resistance compared to controls.  Blunted vasodilator response in the forearm to 
acetylcholine, as a measure of endothelial injury, were also more apparent among OSA 
patients compared to carefully match obese subjects without OSA (Kato et al., 2000). 
Studies of the Relationship Between OSA and Hypertension 
OSA is an independent risk factor for the development of hypertension (National 
Sleep Foundation, 2005).  The association between OSA and hypertension has been 
established by the scientific literature since 1908s (Santos et al., 2006).  The earlier 
findings were mixed and possibly flawed due to the presence of confounders (e.g., 
alcohol consumption, caffeine intake, and family history; Sadikot et al., 2008).  
Subsequently, many published studies considered the flaws in earlier reports of the 
association between OSA and hypertension.  In the past few years, extensive evidence 
obtained from cross-sectional, longitudinal and treatment studies later reported significant 
associations between OSA and hypertension (Sadikot et al., 2008, p. 65).  In a cross 
sectional study of 147 men and women, aged 30-60 years old from the Wisconsin Sleep 
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Cohort Study, the results of the study revealed that mean blood pressure were higher 
among patients with sleep apnea (AHI ≥ 5) versus patients without sleep apnea (131/80 
±.7/1.1 mmHg versus 122/75 ±.9/1.2 mmHg, p < 0.05; Hla et al., 2008).  The 
investigators determined the odds ratio of OSA to hypertension after adjusting for 
confounders such as blood pressure status at baseline, obesity, neck, waist circumference, 
age, sex, weekly alcohol, and cigarette use (Hla et al., 2008, p. 795).  The investigators 
also found a significantly higher proportion of patients with sleep apnea, or a history of 
snoring that experienced higher variability in blood pressure compared to control subjects 
(p < 0.05; Hla et al., 2008, p. 795).  Sleep apnea patients also showed higher odds ratio of 
hypertension in a dose response fashion (Hla et al., 2008, p. 795).  Grote et al., (1999) 
also, cross sectionally analyzed the relationship between OSA and hypertension among 
1087 males and 103 females aged 25 to 85 years old in a sleep study clinic.  The study 
analysis revealed that as adjusted by age, BMI, tobacco, alcohol, and cholesterol, an AHI 
value of ≥40 versus AHI value of  ≤ 5 was an independent predictor of systemic 
hypertension [ORs 4.1] (95% CIs, 2.7-6.5; Grote  et al., 1999, p. 1875).  The largest cross 
sectional study to provide the evidence to support OSA-hypertension relationship came 
from the Sleep Heart Health Study (Nieto et al., 2000).  6132 patients, aged 40 years or 
older were recruited to participate in a cross-sectional study conducted between the 
period of November 1995 to January 1998 (Nieto et al., 2000, p. 1829).  The main 
parameters were AHI index, arousal index, percentage of sleep below 90% oxygen 
saturation, and history of snoring (Nieto et al., 2000, p. 1829).  The study results 
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determined that the prevalence of hypertension were higher among 6132 subjects 
exposed to AHI and other sleep parameters (Nieto et al., 2000, p. 1820).  Despite the 
possibility that the results could be influenced by body mass index; the study showed that 
odds ratio for hypertension were highest among patients with AHI ≥ 30 compared to AHI 
≤ 1.5 (1.37, versus [1.03-1.83], 95% CIs, p = 0.005; Nieto et al., 2000, p. 1831).  The 
OSA and hypertension association was seen regardless of sex, age, ethnic groups, and 
weight (Nieto et al., 2000, p. 1832).  Moreover, Hass et al., (2005) in a cross sectional 
study of OSA patients obtained from the Sleep Heart Cohort Study showed that when 
patients’ ages were stratified by 40-59 years old, to ≥ 60 years old, the association 
between OSA and hypertension were more pronounced among younger patients 
compared to patients ≥ 60 years old, (AHI was significantly associated with higher odds 
ratio of hypertension , (AHI =15 to 29.9, ORs 2.38 [95% CIs, 1.30 - 4.38]; AHI = 30, 
ORs 2.24 [95% CIs 1.10 - 4.54];  Haas et al., 2005).  
Of particular importance is the first longitudinal studies conducted by Peppard et 
al., (2000) which analyzed the relationship between OSA and hypertension.  The 
Wisconsin Sleep Cohort Study (2000) looked at subgroup of state employees from four 
Wisconsin state agencies that had overnight sleep studies at four year intervals (Peppard 
et al., 2000, p. 1378).  After adjusting for systemic hypertension, BMI, neck 
circumference, waist, and hip perimeter, age, gender, tobacco, and alcohol status, the 
odds ratio for the presence of hypertension was 1.42 (95% CIs, 1.13-1.78; Peppard, et al., 
2000,  p. 1378).  Patients had an AHI index of 0.1 – 4.9 events per hour [95% CIs, 1.29-
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3.17] at baseline as compared to none, AHI index of 5.0-14.9 events per hour, and 2.89 
with AHI ≥ 15, (95% CIs, 1.46-5.64; Peppard et al., 2000, p. 1378).  In another 
longitudinal analysis of the relationship between OSA and hypertension, the first 
National Health and Nutrition Examination Survey (n = 4810) measured patients aged 32 
-59 years old using Cox proportional hazards models (Gangwisch, 2006).  Patients were 
followed-up between 1982 and 1992 to determine the incidence of hypertension (defined 
by physician diagnosis, hospital record, or cause of death over 8-10 year follow-up) 
among healthy sleep deprived subjects.  The results of the study revealed that among 
patients who had sleep durations of ≤ 5 hours/night were highly associated with increased 
risk of hypertension (HRs, 2.10; 95% CIs, 1.58-2.79; Gangwisch et al., 2006, p. 833).  
There were also a number of open label studies conducted to determine the effect 
of treatment with CPAP on blood pressure levels of patients with OSA (Cantolla et al., 
2009).  Since 2009, there were already 28 of these open label studies. The majority of 
these open label studies on the effect of CPAP on blood pressure among patients with 
OSA with or without hypertension syndrome showed that patients who were treated with 
CPAP therapy had significantly reduced blood pressure (p = 0.05;  Akashiba et al., 1999; 
Borgel et al., 2004; Doherty et al., 2005; Heitmann et al., 2004; Hla et al., 2002; Huang & 
Chen, 1996; Martinez-Garcia et al., 2007; Robinson et al., 2008; Tun et al., 2003; Wilcox 
et al., 1993 ).  There were also a number of cross-over and parallel group studies that had 
looked at the relationship between OSA and hypertension.  One of these cross-over, 
parallel group studies  shown that the effect of CPAP on blood pressure among patients 
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with OSA similarly showed dropping of systolic blood pressure of 2.00 (-5,07-9.07), and 
diastolic blood pressure of 2.00 (-2.38-6.38) among patients treated with 29 weeks of 
CPAP (Barbe et al., 2004).  
The overall results of these studies strongly suggested that dose response 
association between OSA and hypertension were independent of confounding factors.  
The sample sizes of the majority of studies were performed in large enough sample sizes 
to obtain statistical significance.  The majority of the studies however were performed 
among white Caucasian men. So the lack of knowledge of associations, much less the 
causality between OSA and hypertension among women, men and specific races are 
enormous.  Additionally, obesity is typically related with the association between OSA 
and hypertension among White populations (Wolk et al., 2003). The interaction between 
obesity and OSA stemmed from involvement of similar multiple pathophysiological 
mechanisms and consequences (Davy et al., 2004).  However, obesity is not a common 
problem among Asians (Ip et al., 2001).  The lack of knowledge of the association 
between OSA and hypertension among Asians and the effects of other risk factors 
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Risk Factors Associated with OSA and Hypertension: 
Review of Current Literature 
Age 
Age is an important risk factor in the development of both OSA and hypertension.  
Age related changes in arterial structure and function lead to decreased distensability of 
the large vessels (Franklin et al., 1997).  The enlargement of the vessels contributes to 
increase pulse wave activity, increase myocardial demand, and late systolic blood 
pressure augmentation (Franklin et al., 1997, p. 308).  The Nurses’ Health Study I, a large 
cohort of 83,882 non- hypertensive women aged 27 to 44 years, determined that older 
age, aside from other four risk factors (e.g., BMI, physical activity, frequency of aspirin 
use, and alcohol consumption) increased the incident hypertension (Forman  et al., 2009).  
Participants aged 50 and younger had the lowest risk for all the five factors associated 
with hypertension, while women aged 61 and older had a hazard ratio of 0.62 (95% CIs, 
0-.51-0.75; Forman et al., 2009, p. 401).  Cordero et al., (2011) in a multicenter, cross-
sectional and observatory registry of 10,743 patients with hypertension from cardiology 
and primary care clinics showed that 55.4% of patients had controlled blood pressure and 
slighter higher mean age of 66 years old.  The STRONG Heart Study (2006) a 
longitudinal study of 4549 American Indian showed that hypertension incidence was 
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>38% (p= 0.051) higher among >65 years of age compared to patients aged 45-54 years 
of age (Wang et al., 2006).  
Large epidemiological studies have been conducted exclusively to look at the 
effects of controlling hypertension on the aging population. One of these studies, Systolic 
Hypertension in the Elderly (SHEP) study screened 447,921 and enrolled 2,365 subjects 
assigned to active treatment (chlorthalidone 12.5 or 25 mg/day, and as needed, addition 
of atenolol 25 or 50 mg/day or reserpine, 0.05 or 0.10 mg/day), and 2, 371 to placebo, 
(SHEP Cooperative Research Group, 1991). The average blood pressure 170 mmHg/77 
mmHg, with participants mean age of 72 years. The main outcome measures were 
nonfatal and fatal (total) stroke, while the secondary measures included cardiovascular 
and coronary morbidity and mortality, all-cause mortality, and quality of life measures. 
The results of the study showed that after an average follow-up of 4.5, the average blood 
pressure among the placebo group was 155 mmHg/72 mmHg, while the average blood 
pressure for the treated group was 143 mmHg/68 mmHg, (SHEP Cooperative Research 
Group, p. 3244, 1991). The 5-year incidence of total stroke was 5.2 per 100 participants 
for active treatment and 8.2 per 100 for placebo. Additionally, the relative risk by 
proportional hazards regression analysis was 0.64 (p = .0003) for the secondary end point 
of clinical nonfatal myocardial infarction plus coronary death, while the relative risk was 
0.73 for major cardiovascular events (relative risk, 0.68) and the relative risk was 0.87 for 
death from all causes.  
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Bixler et al., (1998) and other several studies have shown that OSA prevalence 
increases with age. The study also showed that among men, OSA based on AHI ≥ 10 
events/h was 3.2%, 11.3%, and 18.1% among 20- to 44-year, 45- to 64-year, and 61- to 
100-year age groups, respectively (Bixler et al., 1998, p. 2289).  
With advancing aging, pathologically it affects hypertension by contributing to 
increase in large arterial stiffness (Benetos et al., 2002). While, symptomatically in a 
majority of men and women aged 45 and older, manifestations of sleep related difficulties 
are highly common (Bixler et al., 2001).  
Indeed it has been shown in several researches that age increased the prevalence 
of OSA associated to hypertension; however, whether it increases the risk of prevalence 
of OSA association to hypertension among middle aged Asians is uncertain. 
Craniofacial features 
Craniofacial features play a significant effect on the occurrence of OSA among 
Asians (Aihara et al., 2012).  Davidson et al., (2005) postulated that evolutionary changes 
in the upper respiratory tract inclined men to OSA.  The study revealed that among 133 
male with OSA who underwent unattended multi-channel home sleep studies had 
positive correlation between AHI, klinorchy, laryngeal descent, and craniobase 
angulation (Davidson et al., 2005, p. 497).  Numerous studies involving the use of 
various measures including radiography, computerized tomography, and magnetic 
resonance imaging showed that craniofacial abnormalities associated with OSA include 
retrognathia, tonsillar hypertrophy, enlarged tongue or soft palate, inferiorly positioned 
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hyoid bone, maxillary and mandibular retro position, and decreased posterior airway 
space can narrow upper airway dimensions (Cistulli et al., 1996). Aihara et al., (2012) in 
a cross sectional study of 134 Japanese male patients revealed from multiple regression 
analysis that age, BMI, position of hyoid bone, and proximal airway resistance were 
significantly related to AHI (p < 0.05).  Chang et al., (2008) in a cross-sectional study of 
84 males and 15 female Chinese patients from sleep centers in Taipei Veterans General 
Hospital from July 2002 to June 2006 craniofacial measurements of gnathion-gonion, 
anterior superior hyoid mandibular plane, posterior nasal spine to the velum tip, and 
widest point of the soft palate were positively correlated to AHI.  
Regardless of the absence of craniofacial abnormalities, slight difference in the 
maxillary or mandibular size can be a risk factor to the development of OSA (Punjabi et 
al., 2008).  A qualitative and meta-analysis of the literature explained that mandibular 
body length best predicted the increased risk of OSA (Miles et al., 1996).  
However, differences in craniofacial morphology can explain the variability of 
risk among certain ethnic groups (Punjabi et al., 2008, p. 139).  A study conducted among 
Chinese patients revealed that the crowded upper airway and relative retrognathia 
compared to Whites contributed to OSA risk (Lam et al., 2005).  The craniofacial 
features, like shorter cranial base and acute cranial base flexure affected the incidence of 
OSA of other Asians (Li et al., 2000). Based from these evidences, clearly it showed that 
given the differences among Asians groups, studying the effects of these craniofacial 
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differences in the risk of OSA and its relationship to hypertension is of paramount 
importance. 
Obesity 
The Wisconsin Sleep Study, the Sleep Heart Study, Cleveland Family Study and 
others have shown that obesity is not only a significant risk factor for OSA but for 
hypertension as well (Punjabi, 2008).  Moreover, the Wisconsin Sleep Study described a 
one standard deviation in BMI was associated with four-fold intensification OSA 
prevalence (Young et al., 1993).  Epidemiological evidence among various White, 
Korean, and Chinese populations had also described excess body weight as highly 
correlated with increased in OSA prevalence (Duran et al., 2001; Ip et al., 2001; Ip et al., 
2004; Kim et al., 2004; Peppard et al., 2000; Young et al., 1993).  Epidemiological 
evidence among hypertension studies had also shown that obesity was also associated 
with inducing and accelerating renal complications in essential hypertension (Narkiewicz, 
2006).  However, an interesting observation made by studies conducted abroad showed 
that while Asians were less obese than Whites, the disease prevalence for a given sex, 
age, and BMI was higher compared to Whites (Li, et al., 2000; Ong & Clerk, 1998).  
Despite the vast amount of evidence to support increased prevalence of obesity to 
OSA and hypertension, controversy still remains as to whether this risk factor reflect an 




Both OSA and hypertension are pervasive disorders that affect significant 
proportion of the United States population.  The sufficient component cause theory 
supports the ideology of multifactorial etiology in the association between OSA and 
hypertension.  Asians are underrepresented in OSA and hypertension studies, even as 
their great number in the US population is steadily increasing.  There have been 
significant amount of studies that had shown the association between OSA and 
hypertension.  Again these studies do not significantly represent Asians, thus these 
observed OSA and hypertension relationships have not been fully recognized.  A better 
understanding of the factors contributing to the observed OSA and hypertension 
association among Asians is warranted.  Knowledge of other mitigating risk factors like 
craniofacial features might inform the development of specific management, treatment 
and prevention strategies that can confer optimization of treatment of these diseases. 
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Chapter 3: Research Method 
Introduction 
OSA-hypertension epidemiology has been well researched among predominantly 
White populations; whereas data for middle-aged Asians are limited.  The compelling 
evidence of the association of OSA and hypertension has mostly been based on White 
populations specifically those residing in North America, Europe, and Australia and may 
not be applicable to Asians (Villanueva et al., 2005).  Studies done in Asia indicate that 
the prevalence rate of OSA among Asians is probably comparable to or even higher than 
the rate among U.S and European Whites (Ip et al., 2001; Kim, et al., 2004).  However, 
these rates could be different from the actual rates among Asians living in the United 
States.  The difference in rates seen in various studies can be attributed to a number of 
factors that may confound the results, including differences in sleep study techniques, 
clinical outcomes, genetic factors, and diet and lifestyle (Villanueva et al., 2005, p. 419).  
The difference in rates can also be attributed to differences in fundamental characteristics 
such as age, sex, person, place, time, and race (Labarthe, 2011).  Although a number of 
epidemiological studies linking OSA with increased risk of hypertension have been 
performed, few studies using similar methods have observed these relationships among 
middle-aged Asians in the United States.  It is also uncertain whether in the United States 
OSA is common among Asians and if OSA is also associated with hypertension. 
This section of the study addresses the research design and rationale, 
methodology, and threats to validity. 
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Research Design and Rationale 
A cross-sectional study design was used to determine (a) the prevalence rate of 
OSA among middle-aged Asian patients (Chinese, Filipino, Vietnamese, Asian Indian, 
Korean, Taiwanese, Japanese, and Singaporean) in San Jose, CA; (b) the association 
between OSA and hypertension, and (c) the association of other risk factors--body mass 
index (BMI); Mallampati score (MS); the Epworth Sleepiness Scale (ESS), and Apnea-
Hypopnea Index (AHI) with hypertension as the outcome.  The cross-sectional design of 
this study was the suitable study design to describe the burden and distribution of OSA in 
association with hypertension among this population of interest (Babbie, 2010).  This 
study design also allowed me to make observations about the prevalence and 
characteristics of this disease in a distinct population during a certain period of time 
(Gordis, 2004, p. 195).  The general design of a cross-sectional study consist of looking 
at a slice of the population to examine characteristics associated with a disease by 
comparing cases to noncases and performing predefined measurements or ascertainments 
(Gordis, 2004, p.196).  This can be accomplished by examining a population of n persons 
for the study, then identifying the presence or absence of the disease for each subject 
(Gordis, 2004, p. 197).  This study design allows the determination of prevalent cases at a 
fixed point in time.  One constraint of this study design is that although association may 
be obtained for the possible risk factor(s), temporal association cannot be highly 
determined (Gordis, 2004, p. 198).  This type of study design is appropriate for 
determining the prevalence of OSA with hypertension (Gordis, 2004, p. 195).  The other 
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limitation of a using cross-sectional study design is that the confounding factors may not 
be equally distributed between groups (Babbie, 2010, p. 106).  This unequal distribution 
of confounding factors can lead to bias and misinterpretation (Babbie, 2010, p, 106).  
Biases include selection, recall, length, and biased sampling.  Selection bias can be 
addressed by ensuring that the study is powered enough to represent the target 
population.  Recall bias can be addressed by clearly describing the problem and gaining a 
thorough understanding of the available evidence before data collection (Varkevisser et 
al., 2003).  A clearly defined problem can enable the investigator to formulate specific 
objective(s) and sample the right population of interest (Varkevisser et al., 2003, p.195).  
Length biased sampling can be eliminated by knowing the duration of the disease of 
interest to avoid overrepresentation or underrepresentation of the said disease 
(Varkevisser et al., 2003, p. 195).  The other variables of interest were age, gender, 
smoking consumption, body mass index (BMI), Epworth Sleepiness Scale (ESS), 
Mallampati score (MSS), and Apnea and Hypopnea (AHI). 
Methodology 
Population 
The data that were generated for this study originated from patients living in San 
Jose, CA. The target populations for this study were Asians (Chinese, Filipino, 
Vietnamese, Asian Indian, Korean, Taiwanese, Japanese, and Singaporean) residing on 
southern side of San Jose, CA who had visited the sleep clinics between January 1, 2008 
to December 31, 2011.  A total of 462 middle-aged Asian patients were needed to 
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perform this study and were randomly selected from three major sleep study clinics in 
San Jose, CA.  The recruitment and selection of the eligible patients were accomplished 
by random sampling.  The inclusion criteria for these patients were the following: (a) 
men and women between 35 and 60+ years of age who had observed apneas, daytime 
fatigue, daytime sleepiness, or snoring who were referred to sleep study clinics; (b) 
diagnosis of OSA verified by overnight polysomnograms, and (c) a systolic blood 
pressure [SBP] level of 140mmHg, and a diastolic blood pressure [DBP] level of 90 mm 
Hg).  Eligible patients needed to have a completed physical examination.  The exclusion 
criteria for the study included patients with physical or psychological incapacity, no self-
reported history of hypertension, no current or self-reported treatment for OSA, no 
previous treatment for snoring or any previous CV event (myocardial infraction, unstable 
angina, transient ischemic stroke, or attack, myocardial revascularization), chronic 
disease, and drug or alcohol addiction. Patients were also excluded if they had severe 
congestive heart failure (NYHA class IIIb or IV), known cardiomyopathy, valvular 
disease, coronary artery disease, diabetes mellitus, current active liver disease, 
unexplained elevated serum creatine kinase (CK > 3XULN), cancer,  uncontrolled 
hyperthyroidism, or other important comorbidities. 
Sampling and sampling procedures 
The sample population for the study was independently and randomly selected 
from three sleep study clinics in San Jose, CA. The sample size needed was calculated 
and a third of the sample was collected from each clinic.  
56 
 
A simple random sampling procedure was used to select the study participants.  
The research study of interest involved widely dispersed large populations of patients. 
The use of simple random sampling allowed equal opportunity for all sets within the 
population to be sampled (Anderson & Finn, 1997).  In cross-sectional studies, the power 
is estimated by factoring in the sample size among the exposed and nonexposed with the 
desired confidence interval (Portney & Watkins, 1993, p. 236).  In order to determine a 
sample size that would be sufficient to power the study, the following considerations 
were used: margin of error -- 5%; confidence level --95%; estimated prevalence of OSA 
based on limited studies among Asians outside of the United States -- 4%, (Cantolla, et 
al., 2009; Kamil, et al., 2007; Kim, et al., 2004; Punjabi, 2008; Vozoris, 2012).  The 
sample calculation based on the following equation: 
N= t² x p(1-p) 




Where n is the sample size, t is confidence level at 95% (standard value of 1.96), 
p is the estimated prevalence, and m is the margin of error at 5% (standard value of 0.05) 
Kadam & Bhalerao, 2012).  
                                n =  1.962 x .4 (1- .4) 
                                              0.052 




                                              0.0025 
                                n =  .9219 
                                        0.0025 
                                n =  460 
460 divided by three clinics is 153.333.  The number of subgroups in each of the 
three clinics to be sampled is an important consideration in the study.  Because an equal 
number of male and females subjects in each of the three clinics was considered, 
n=153.33 will be rounded to whole persons to154.  
Based from this calculation, the number of subjects needed for the analysis is 462 
(Kadam & Bhalerao, 2010).  The total patients (n) equals’ 462 subjects will be divided 
among the three sleep clinics.  The total patient (n) for each sleep clinics is 154. A 







Procedures for Recruitment, Participation, and Data Collection 
All the study subjects who were recruited were approved by the Human and 
Research Committee of Walden University (Institutional Review Board approval 03-25-
14-0153639). The study was also conducted in accordance to the principles of human 
research protections as specified by the Declaration of Helsinki.  All study subjects who 
qualified for the study had to meet the study inclusion, and exclusion criteria.  The data 
that were collected for the study were obtained with the use of paper and electronic 
medical records (EHR).  Since, this study only used secondary data; all data collected 
were subjected to confidentiality.  The data regarding patient demographics, patient’s 
history, anthropometric measurements, physician diagnoses, and laboratory results were 
extracted from paper and electronic health records.  In order to ensure data 
confidentiality, I obtained sample confidentiality agreement from each of the sleep study 
clinics.  The data collected were extracted from patient records that were identified by the 
medical staff as Chinese, Filipino, Vietnamese, Asian Indian, Korean, Taiwanese, 
Japanese, and Singaporean.  The cross-sectional nature of the study, as well as the use of 
paper and electronic health records does not require debriefing patients, or any need for 
follow-ups.  The physician in charge in each of the three sleep study centers in San Jose, 
CA provided permission to use data obtained from the paper and electronic health record.  





Sample data use agreements were obtained to ensure that data obtained were limited to 
the prevalence rate of OSA in association with hypertension among Asian Americans in 
San Jose, CA. 
Clinical Definition of OSA 
The clinical definition of OSA was in accordance with the Adult OSA Task Force 
of the American Academy of Sleep Medicine (2009) as “occurrence of daytime 
sleepiness, loud snoring, witnessed breathing interruptions or awakenings due to gasping 
or choking in the presence of at least five obstructive respiratory events (apneas, 
hypopneas or respiratory effort related arousals) per hour of sleep”.  OSA was also 
clinically defined by the presence of 15 or more of observed respiratory events per hour 
of sleep in the absence of sleep related symptoms (AASM, 2009, p. 263).  The categories 
of OSA were defined according to the AHI groups, as follows; group 1 (AHI < 5); group 
2 (5 ≤ AHI < 15); group 3 (15 ≤ AHI < 30); and group 4 (AHI ≥ 30; AASM, 2009, p, 
263-264). 
Clinical Definition of Hypertension 
Hypertension was defined as high blood pressure, in which the arteries have 
persistent high arterial pressure.  Based from the Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC 7), the categories of hypertension will be; group 1 (pre-hypertension,  SBP, 120-
139 mmHg, DSP, 80-89 mmHg); group 2 ( stage 1 hypertension,  SBP, 140-159 mmHg, 
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DSP, 90-99 mmHg), and group 3 ( stage 2 hypertension, SBP ≥ 160 mmHg, DSP, ≥ 100 
mmHg).  
Polysomnography 
All patients were qualified if they did at least one overnight polysomnographic 
study at a sleep center in San Jose, CA.  The polysomnographic study will include the 
following measurements: electroencephalogram (EEG, C3 and C4), electro-oculogram 
(EOG), chin, and leg electromyogram (EMG), and electrocardiography, (ECG, modified 
V2 lead).  Oronasal flow, thoracic, and abdominal measurements by inductive 
plethysmography and oxygen saturation will be used to measure respiration.  Sleep 
disruption and EEG arousals will be detected by PSG recordings from skin surface 
electrodes per current AASM criteria for sleep/wake and cortical arousal determination, 
(Chang, et al., 2008).  All the records were scored according to scoring criteria 
established by Rechtschaffen and Kales (1968), the American Sleep Disorders 
Association (Thornton et al., 2012).  This scoring criterion, used in various populations, 
including Asians based from studies conducted outside the U.S, was validated to be fairly 
accurate in the diagnosis of OSA (Thornton et al., 2012, p. 425).  This scoring criterion 
has been the standard scoring system used by physicians to diagnose OSA. 
Sleepiness 
The study used the definition of sleepiness using the Epworth Sleepiness Scale 
(ESS). This is an eight item questionnaire, with scores ranging from 0 (the least sleepy) 
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to 24 (the most sleepy) Chung et al., 2000).  The ESS total score is the sum of the eight 
scores with points ranging from 0 to 24 (Gonzales et al., 2011). 
BP Measurements 
A non-invasive blood pressure measurement in office for at least two 
measurements was used to determine diagnosis of hypertension. 
Neck Circumference 
The study used neck circumference measurement as placing the tape at the level 
of the cricothyroid membrane the night before the polysomnography. 
Body Mass Index (BMI) 
The subjects BMI were calculated by dividing a person’s weight in kilograms (kg) 
by the person’s height in meters squared.  BMI measurement was also be calculated by 
multiplying weight in pounds (lbs.) by 705 and then dividing by height in inches (in.) 
twice.  A healthy BMI is in the range of 18.5 to 24.9, while BMI over 30 is considered 
obese. 
Mallampati Score 
The Mallampati Scoring System (MSS) was used to assess the patients’ 
oropharyngeal region.  The healthcare professional needed to identify the four anatomical 
landmarks in the oropharyngeal region.  MSS was classified according to four groups: 
group 1, Class I (all anatomical structures can be visualized); group 2, Class II (soft 
palate, hard palate and upper portions of the uvula and tonsils can be visualized); group 3, 
Class III (only soft, hard palate and base of the uvula can be visualized); and group 4, 
62 
 





Summary of Variables 
Type of variable Description of variable SPSS Variable Name Coding instructions 
Categorical    
a. Nominal Identification number ID 
 
 
 Sex Sex 0-Female 
   1-Male 
 Race Race 1-Chinese 
   2-Filipino 
   3-Vietnamese 
   4-Asian Indian 
   5-Korean 
   6-Taiwanese 
   7-Japanese 
   8-Singaporean 
 Smoking status Smoking status 0-No 
   1-Yes 
 Hypertension Hypertension status 0-No 
   1-Yes 
 Mallampati score MS score 1-Class1 
2-Class II 
   3-Class III 
4-Class IV 
    
 OSA status OSA status 0-No 
   1-Yes 
 Snoring Snoring 0-No 
   1-Yes 
Numeric    
a. Discrete ESS score ESS score Total ESS score 
 (range from 0=low to 
24=high daytime 
sleepiness) 
 AHI score AHI score AHI score  
(range from 5 and above) 
b. Continuous    
 Age Age (years)  
 BMI BMI  
 Neck circumference Neck circumference 
(inches) 
 







Procedures for Archival Data 
In order to address data integrity, the data was accessed only by qualified users, 
audit trails on all changes will be logged and specific controls over identification codes 
and passwords will be instituted.  Only data pertinent to the study protocol was collected 
and no extra data was collected.  If it is appropriate, cross checks were imposed to ensure 
inclusion/exclusion criteria and procedures are appropriately collected.  Examples of 
cross-checks are age, blood pressure ranges, AHI, etc. Cross checks of procedure 
sequence were also followed.  For example, the study required that polysomnography 
should be done before the determination of OSA; MSS scores were done prior to 
determination of MSS scores, etc.  The study ensured that specific designs for collecting 
analyzable data were followed.  For example, numeric analysis required numeric data, 
and categorical analysis required categorical data.  Standard units for each of the 
measureable data were followed to ensure data collected were reliable and valid.  
Laboratory data collected were reconciled, which mean that each subject have matching 
information, laboratory values were consistent and laboratory ranges were not different. 
The data should also be cleaned.  I avoided duplication errors, eliminated ambiguous 
responses from subjects, and checked missing responses (Prokscha, 2012).  I also 
obtained permission to collect and use data by ensuring that proper forms and 
requirements as per Walden University’s Office of Research Ethics and Compliance 
(IRB) were duly met and submitted prior to data collection. 
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Data Analysis Plan 
The latest version of SPSS, version 21 was used for data analysis.  The analysis of 
patients included in the study was obtained from paper and electronic medical records 
(EMR). EMRs are paperless or digital versions of patients’ charts.  The cleaning and 
screening in patients for data analysis only involved analyzing patient demographics.  
The patient demographics in paper and EHR included gender, age, race, smoking status, 
hypertension status, systolic diastolic blood pressure readings, neck circumference, body 
mass index (BMI), snoring status, Epworth Sleepiness Scale (ESS), Mallampati score 
(MS), Apnea, and Hypopnea Index (AHI).  The other items that were included in the 
paper and EHR database for analysis included medical history, family history, diagnosis 
codes, laboratory data, and prescription data.  
The analysis determined the estimated unadjusted age, BMI, smoking, alcohol 
status, and neck circumference effect on OSA, and its association with hypertension.  
Mean and frequency of distribution were calculated for gender, age, ethnicity, smoking 
status, hypertension status, snoring and OSA status.  Mean, mean standard deviation, 
standard deviation, and variance were also calculated for gender, age, ethnicity, smoking 
status, systolic, diastolic, neck circumference, BMI, snoring, Epworth Sleepiness Scale, 
Mallampati score, Apnea Hypopnea Index, OSA status and AHI groups.  The continuous 
variables were expressed as means ± standard deviation (SD).  The subjects’ age, BMI 
and Mallampati scores were considered independent confounding variables.  The 
variables of interest (BMI, MSS, ESS and AHI) were not adjusted by age.  These 
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variables were analyzed in the study because other epidemiologic evidence conducted 
among predominantly White populations showed that these factors affected the 
prevalence of OSA among Caucasians.  The associations of different variables to 
hypertension were analyzed by logistic regression analysis.  The odds ratios (ORs) of 
OSA association with hypertension were calculated for ethnicity, age, gender, smoking, 
BMI, MSS, ESS, and AHI.  
Descriptive statistics were performed in the defined categorical variables in the 
study. Frequencies tabulations were utilized for gender, sex, race, smoking, and alcohol 
history, elevated blood pressure, and history of hypertension.  Descriptive statistics for 
continuous variables (e.g., age) which enlisted the summary statistics included n, mean, 
mean standard deviation, standard deviation, and variance.  The study also included the 
use of tables to describe and explore the data. 
The specific hypotheses of the study expressed in the null form were statistical 
analyzed by the following 
Null Hypothesis1.  There was no association between OSA and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between OSA and hypertension, the study 
conducted logistic regression analysis. OSA and hypertension were evaluated first as a 
binary response, denoted as either yes or no. SPSS coding was denoted as 0- No and 1-
Yes. Binary response variables described the proportion of the population specified in the 
67 
 
analysis (Grobee & Hoes, 2009).  The binary response variable was calculated using the 
following formulary: 
         ln      Y / (1-Y)     = b0 + b1X1 which calculated the odds.  Where Y is 
representative of the proportion of the subjects with the outcome, the probability of the 
disease is represented by (1-Y), and the probability of the study subjects who do not have 
the disease is represented by ln [Y/ (1-Y)] is the odds of the disease.  Additionally, b0 is 
the intercept for the odds of the disease and X1 is the intercept for the independent 
variable (Grobbee & Hoes, 2009, p. 345). 
The measure of association between the outcome of interest and predictor variable 
was measured using odds ratio.  The level of significance was evaluated at 0.05. 
Null hypothesis 2.  There was no association between age and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between age (continuous variable), and 
hypertension (categorical variable) among a sample of middle aged Asians living in San 
Jose, CA, the study conducted logistic regression analysis.  This type of analysis can 
better explain the functional relationship of OSA and other variables (Wassertheil-
Smoller, 1990).  
The absolute probability or the risk of the outcome for each of the subjects was 
also be calculate using logistic regression by substituting the coefficients for each 
determinants with the use of the formula: 
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..) 
68 
 
The measure of association between the outcome of interest and predictor variable 
was measured using odds ratio.  The level of significance was evaluated at 0.05. 
Null hypothesis 3.  There was no association between gender and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between gender and hypertension 
(categorical variables) among a sample of middle-aged Asians living in San Jose, CA, the 
study conducted logistic regression analysis.  This type of analysis can better explain the 
functional relationship of OSA and other variables (Wassertheil-Smoller, 1990).  The 
absolute probability or the odds of the outcome for each of the subjects was also 
calculated using logistic regression by substituting the coefficients for each determinant 
with the use of the formula: 
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..) 
The measure of association between the outcome of interest and predictor variable 
was measured using odds ratio.  The level of significance will be evaluated at 0.05. 
Null hypothesis 4.  There was no association between smoking consumption and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between smoking and hypertension 
(categorical variables) among a sample of middle-aged Asians living in San Jose, CA. the 
study conducted logistic regression analysis.  This type of analysis can better explain the 
functional relationship of OSA and other variables (Wassertheil-Smoller, 1990).  The 
absolute probability or the odds of the outcome for each of the subjects was also be 
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calculated using logistic regression by substituting the coefficients for each determinant 
with the use of the formula: 
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..) 
The measure of association between the outcome of interest and predictor variable 
was measured by using odds ratio. The level of significance was evaluated at 0.05 level 
of significance. 
Null hypothesis 5.  There was no association between body mass index (BMI) and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between body mass index (BMI) (continuous 
variable) and hypertension (categorical variables) as the outcome among a sample of 
middle aged Asians living in San Jose, CA, the study conducted logistic regression 
analysis.  The binary response variable was calculated using the following formulary: 
lnY/ (1-Y)= b0 + b1X1 which will calculate the odds.  Where Y is representative of 
the proportion of the subjects with the outcome, the probability of the disease is 
represented by (1-Y), and the probability of the study subjects who do not have the 
disease is represented by ln [Y/ (1-Y)] is the odds of the disease.  Additionally, b0 is the 
intercept for the odds of the disease andX1 is the intercept for the independent variable, 
(Grobbee & Hoes, 2009, p. 345). 
Null hypothesis 6.  There was no association between Mallampati Score (MS) and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
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In order to determine the association between Mallampati score (MS) and 
hypertension (categorical variables) among a sample of middle aged Asians living in San 
Jose, CA, the study conducted logistic regression analysis.  This type of analysis can 
better explain the functional relationship of OSA and other variables (Wassertheil-
Smoller, 1990).  The absolute probability or the risk of the outcome for each of the 
subjects was also calculated using logistic regression by substituting the coefficients for 
each determinant with the use of the formula: 
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..) 
The measure of association between the outcome of interest and predictor variable 
was measured using odds ratio.  The level of significance was evaluated at 0.05. 
Null hypothesis 7.  There was no association between Epworth Sleepiness Scale 
(ESS) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between ESS and hypertension (categorical 
variables) among a sample of middle-aged Asians living in San Jose, CA, the study will 
conduct logistic regression analysis.  This type of analysis can better explain the 
functional relationship of OSA and other variables (Wassertheil-Smoller, 1990).  The 
absolute probability or the odds of the outcome for each of the subjects was also 
calculated using logistic regression by substituting the coefficients for each determinant 
with the use of the formula: 
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..) 
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The measure of association between the outcome of interest and predictor variable 
was measured using odds ratio.  The level of significance was evaluated at 0.05. 
Null hypothesis 8.  There was no association between Apnea-Hypopnea index 
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
In order to determine the association between Apnea-Hypopnea Index (AHI) and 
hypertension (categorical variables) among a sample of middle aged Asians living in San 
Jose, CA, the study conducted logistic regression analysis.  This type of analysis can 
better explain the functional relationship of OSA and other variables (Wassertheil-
Smoller, 1990).  The absolute probability or the odds of the outcome for each of the 
subjects was also calculated using logistic regression by substituting the coefficients for 
each determinant with the use of the formula: 
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..) 
The measure of association between the outcome of interest and predictor variable 
was measured using odds ratio.  The level of significance was evaluated at 0.05. 
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Threats to Validity 
Threats to validity can be external or internal (Groves et al, 2009).  The external 
validity addressed the question of how the results of the study could be generalized to the 
population (Groves et al., 2009, p. 373).  In order to address the external validity of the 
study, the study strictly adhered to the study’s inclusion and exclusion criteria.  The study 
also clearly defined the variables; provided detailed description of the study 
methodology; clearly explained the instrumentation, and measurements used in the study 
and openly provided the protocol for data collection (Groves et al, 2009, p. 373).  There 
are various types of internal validity associated with cross-sectional studies. Construct 
validity as such is one of them.  Construct validity assures that possible causal 
relationships exists between a variable to another. In this particular study, numerous 
epidemiological studies have shown such relationships among predominantly White 
populations. Thus, this study postulated that such relationship can also be seen among 
Asian patients.  There other internal validity issue for the study. Face validity being one 
of them, was addressed by ensuring that the appropriate statistical measurement for the 
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various variables to be used was appropriate for study analysis.  This was established by 
consulting statistical references and literatures with similar study design, methods, and 
patient population.  The other internal validity issue was selection of study subjects.  
Although, I did a careful analysis of the existing literature, and considered all known 
variables that may affect the study results, other confounders can still influence the 
results of the study. These include other existing medical conditions, and other risk 
factors that may affect the disease. Selection maturation, an internal validity issue, can 
occur when study subjects mature at different speeds (Asmundson et al., 2002).  In cross -
sectional studies such as this one, although subjects maybe of the same age, other factors 
may affect outcomes, and thus the study may not be able to differentiate between 
maturation and cohort differences (Olsen & St. George, 2004).  The study tried to address 
this issue by ensuring that age is factored into the analysis. 
Ethical Concerns 
The study strictly adhered to the widely accepted standards for ethical, 
professional and scientific conduct of the study from study design and implementation.  
The study adhered to the principles as set forth by Walden University’s IRB, which 
included confidentiality agreement, data use agreement, and authorization to disclose 
private health information (PHI).  In order to do this, the study strictly viewed all patient 
data as highly confidential, and respected the study subject’s cultural and social 
differences (Groves et al., 2009).  The investigator also observed the highest level of 
professional integrity in the conduct of all the stages of the study (Groves et al., 2009, p. 
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373).  The investigator also made sure that the findings was reported accurately (Groves 
et al., 2009, p.375).  The study also advocated following appropriate quality control 
procedures (Groves et al, 2009, p. 375).  All materials were documented in relation to the 
ethical conduct of the study (Groves et al., 2009, p. 375).  All data procured abided by the 
standards set forth by Walden University’s IRB process that included: obtaining consent 
forms, confidentiality agreements, letter of cooperation, data collection request, data use 
agreement, and authorization to disclose PHI. If participants refuse to grant such request; 
the investigator will comply, and obtain information from subjects who would consent to 
the use of PHI. 
Summary 
In order to determine the prevalence of OSA in association with hypertension, the 
study conducted a cross-sectional survey of middle-aged Asians living in San Jose, CA.  
The study analyzed paper and electronic medical records of 462 patients randomly 
selected at three sleep study centers in San Jose, CA.  The study employed random 
sampling to eliminate bias in participant selection and limited the possibility of 
confounders affecting the results of the study.  The study also employed frequencies 
tabulations and logistic regression analysis to determine the prevalence rate of OSA in 
association with hypertension together with other risk factors including age, gender, 
smoking status, ESS, BMI, MSS, and AHI.  All data that I collected for the study, 
including the processing of data collection, management, and data analysis abided with 
the rules and regulations as set forth by Walden University’s Office of Research Ethics 
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and Compliance (IRB).  This guaranteed that all data obtained and all outcomes presented 
were all under the pretext of highest standards of integrity and ethical procedures.  
The next chapter will discuss the data collection and results. 
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Chapter 4: Results  
Introduction 
The main purpose of this quantitative cross sectional study was to determine (a) 
the prevalence rate of OSA among middle-aged Asian patients (Chinese, Filipino, 
Vietnamese, Asian Indian, Korean, Taiwanese, Japanese, and Singaporean)  in San Jose, 
CA.; (b) the association between OSA and hypertension; and (c) the association of other 
risk factors --age, gender, smoking, body mass index (BMI); Mallampati score (MS), the 
Epworth Sleepiness Scale (ESS) and Apnea-Hypopnea Index (AHI) --with hypertension 
as the outcome. 
This section addresses the results of the study. 
Results 
Research Questions and Hypotheses 
The overarching research question involved determining the association of OSA 
and other risk factors as related to hypertension among middle-aged (40-60+ years old) 
Asians living in San Jose, CA.  To answer the above research question, the following sub 
questions were examined. 
Research Question 1.  What was the association between OSA and hypertension 
among a sample of middle-aged-Asians living in San Jose, CA? 
Null Hypothesis 1.  There was no association between OSA and hypertension 
among a sample of middle-aged-Asians living in San Jose, CA. 
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Alternative Hypothesis 1.  There was an association between OSA and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 2.  What was the association between age and hypertension 
among a sample of middle-aged-Asians living in San Jose, CA? 
Null Hypothesis 2.  There was no association between age and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 2.  There was an association between age and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 3.  What was the association between gender and hypertension 
among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 3.  There was no association between gender and hypertension 
among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 3.  There was an association between gender and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 4.  What was the association between smoking status and 
hypertension among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 4.  There was no association between smoking status and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 4.  There was an association between smoking status and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
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Research Question 5.  What was the association between body mass index (BMI) 
and hypertension among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 5.  There was no association between body mass index (BMI) 
and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 5.  There was an association between body mass index 
(BMI) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 6.  What was the association between Mallampati score (MS) 
and hypertension among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 6.  There was no association between Mallampati score (MS) and 
hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 6.  There was an association between Mallampati score 
(MS) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Research Question 7.  What was the association between Epworth Sleepiness 
Scale (ESS) and hypertension among a sample of middle-aged Asians living in San Jose, 
CA? 
Null Hypothesis 7.  There was no association between Epworth Sleepiness Scale 
(ESS) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 7.  There was an association between Epworth Sleepiness 




Research Question 8.  What was the association between Apnea-Hypopnea Index 
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA? 
Null Hypothesis 8.  There was no association between Apnea-Hypopnea Index 
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA. 
Alternative Hypothesis 8.  There was an association between Apnea-Hypopnea 
Index (AHI) and hypertension among a sample of middle-aged Asians living in San Jose, 
CA. 
The analysis determined the association between OSA, age, gender, smoking 
status, body mass index, Mallampati score, Epworth Sleepiness Scale, and apnea-
hypopnea index to hypertension.  Means, standard deviation, and frequency of 
distribution were calculated for continuous independent variables such as age, gender, 
ethnicity, sex, and BMI.  
The purpose of this chapter is to provide the précis of the collected data, the 
statistical analyses and mechanics of the analysis.  
Data collection 
This study used cross sectional design.  After obtaining Institutional Review 
Board approval (03-25-14-0153639), data were collected among Asian men and women 
patients between the ages of 35 and 60+ years of age who had observed obstructive sleep 
apneas living in San Jose, CA or Santa Clara County.  For this study, eligible patients 
were randomly selected from each of the three identified sleep study clinics located in 
San Jose, CA who were seen from January 1, 2008 to December 31, 2011.  Inclusion 
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criteria were the following: a. men and women 35- 60+ years of age who had observed 
apneas, daytime fatigue, daytime sleepiness, or snoring who were referred to sleep study 
clinics; b. diagnosis of OSA verified by overnight polysomnograms; and c. a systolic 
blood pressure [SBP] level of 140mmHg and a diastolic blood pressure [DBP] level of 90 
mm Hg).  All eligible patients completed a physical examination.  Consequently, 
exclusion criteria were applied to patients with physical or psychological incapacity, no 
self-reported history of hypertension, no current or self-reported treatment for OSA, no 
previous treatment for snoring or any previous CV event (myocardial infraction, unstable 
angina, transient ischemic stroke, or attack, myocardial revascularization), chronic 
disease, and drug or alcohol addiction.  Patients were also excluded if they had severe 
congestive heart failure (NYHA class IIIb or IV), known cardiomyopathy, valvular 
disease, coronary artery disease, diabetes mellitus, current active liver disease, 
unexplained elevated serum creatine kinase (CK > 3XULN), cancer,  uncontrolled 
hyperthyroidism, or other important comorbidities.  Personnel at all three sites provided 
consent by signing the data collection request form and data use agreement forms.  All 
sites were furnished with a copy of the approved dissertation proposal. 
Data collection started in July 2014 and ended in October 2014.  The 
polysomnographic information of patients was obtained by randomly choosing the 
appointment days that fall between January 1, 2008 and December 31, 2011.  Eligible 
patients were drawn from a list of patients that each physician at each site identified.  The 
list contained no patient names, but did contain dates.  A medical assistant then retrieved 
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the patient records and provided the data needed for analysis.  The following data were 
collected from the medical records of eligible patients: age, gender, ethnicity, smoking 
status, history of hypertension, systolic blood pressure, diastolic blood pressure, neck 
circumference, Body Mass Index (BMI), snoring (yes or no), Epworth scale (ESS), 
Mallampati score, and Apnea Hypopnea Index (AHI). A total of 462 middle-aged Asian 
patients (Chinese, Filipino, Vietnamese, Asian Indians, Korean, Taiwanese, Japanese, 
and Singaporean) were randomly selected among the three sleep study clinics.  From 
Sites 1 and 2, data were collected on a totaled of 308 patients; however, Site 3 only had 
80 eligible patient’s data.  In order to meet the requirement 154 from each site, additional 






Demographic Characteristics of the Study Sample  
Characteristics  N % 
Gender   
Male 278 60.2 
Female 184 39.8 
Age bracket   
35-40  
40-50 
50-60    
60-70 
70-80  









Singaporean                                                                                                                                                                                                  
 
  49  
  75  
  80 
107 
114 
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  48 
    5 
    4 












   8.0 
 10.4 
   1.1 
   0.865 
   1.7 
   0.216 
Smoking status   
Yes   96 20.8 
No 366 79.2 
Hypertension   
Yes 319 69.0 
No 143 31.0 
Snoring   
Yes 454 98.3 
No    8   1.7 
OSA   
Yes 416 90.0 
No   46 10.0 
 
More than half of the sampled populations were males, about 60.2%, and only 
39.8% were females.  A larger proportion of the population falls between the ages of 70 
and 80 years of age (24.5%), while there were few participants that were 80 years and 
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above (7.7%).  The mean age of the sampled population is 61 years old. The percentages 
of the sampled population were as follows: Chinese (47.6%), Filipinos (30.1%),  Asian 
Indians (10.4%), Vietnamese (8.0%), Japanese (1.7%), and  Korean (1.1%).  There were 
very few Taiwanese (0.865%) and Singaporeans (0.216%).  Table 6 provides the 
demographic characteristics of the sampled population. 
Table 5 
Demographic Characteristics of the Sampled Population 
Variables n Sum Statistic Mean SE SD Variance 
Gender 462 278 .60 0.023 .490 .240 
Age 462 28355.00 61.3745 .69522 14.94315 223.298 
Ethnicity 457 882 1.93 0.58 1.232 1.517 
Smoking 
status 
462 96 .21 0.019 .406 .165 
Systolic 462 57802 125.11 .679 14.598 213.098 
Diastolic 462 34657 75.02 .469 10.080 101.616 
Neck 
circumference 
462 6739.3 14.587 .0932 2.0028 4.011 
BMI 462 12300.53 26.6245 .24190 5.19939 27.034 
Snoring 462 454 .98 .006 .131 .017 
Epworth scale 462 5618 12.16 .206 4.432 19.640 
Mallampati 
score 
462 1714 3.71 .028 .606 .367 
AHI 462 14504.2 31.394 1.1910 25.600 655.362 
OSA 462 416 .90 .014 .300 .090 
AHI 
GROUPS 
462 1024 2.22 .061 1.303 1.697 
Valid N(list 
wise) 
457      
Note. BMI= body mass index; AHI = Apnea-Hypopnea Index 
 
There were 366 non-smokers compared to 96 smokers. 319 patients were 
hypertensives compared to 143 non hypertensive patients.  The mean systolic blood 
pressure of the sampled patients is 125 mmHg and mean diastolic blood pressure is 75 
mmHg.  The subjects had a mean neck circumference of 14.58 cm; body mass index 
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average of 26.62; Epworth Sleepiness Scale average of 12.16; average Mallampati score 
of 3.71, and mean Apnea-Hypopnea Index of 31.39.  The majorities of the participants 
were snorers (98.3%) and diagnosed with obstructive sleep apnea (90%).  Table 7 below 
provides the descriptive summary of the Apnea Hypopnea Index (AHI) groups of the 
study. 
Table 6 
Apnea Hypopnea Index (AHI) Groups 
AHI Frequency % Valid % Cumulative % 
Under 5.999 60 13.0 13.0 13.0 
6-14.999 76 16.5 16.5 29.4 
15-29.999 126 27.3 27.3 56.7 
30-49.999 104 22.5 22.5 79.2 
Over 50 96 20.8 20.8 100.0 
Total 462 100.0 100.0 100.0 
Note. AHI = Apnea-Hypopnea Index 
Research question 1.  What was the association between OSA and hypertension 
among a sample of middle aged Asians living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between OSA and hypertension among a sample of middle aged Asians living in San 
Jose, CA.  There were 462 cases included in the analysis.  
Table 8 below illustrates the logistic coefficient, Wald test and odds ratio for the 
predictor variable which is hypertension. Using a .05 criterion for statistical significance, 
in a sample of middle aged Asians living in San Jose, CA, hypertension had no 




Logistic Regression Analysis to Determine Association Between OSA and Hypertension 
    Variables in equation  








Step 1a OSA(1)  .085 .332 .066 1 .798 1.089 .568 2.087 
 Constant .726 .315 5.327 1 .021 2.067   
Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable (s) entered on Step 1:OSA  
 
In this analysis, the confidence interval for the variable hypertension (OR = .919) 
ranges from .568 to 2.087. Based from this analysis, I failed to reject the null hypothesis. 
There was no association between OSA and hypertension among a sample of middle 
aged Asian living in San Jose, CA. 
Research question 2.    What is the association between age and hypertension 
among a sample of middle aged Asians living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between age and hypertension among a sample of middle aged Asian living in San Jose, 
CA. There were 462 cases included in the analysis.  Table 9 showed the logistic 





Logistic Regression Analysis Between Age and Hypertension 
 Variables in equation  












Age .089 .009 93.792 1 .000 1.093 1.093 1.112 
 Constant -4.362 .524 69.205 1 .000 .013   
Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable (s) entered on Step 1: Age 
 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, age had significant association with hypertension, x2 (1, N 
= 462) = 127.932, p < .000.  Age recorded an odds ratio of 1.093.  This indicated that 
older middle age Asians living in San Jose, CA were 1 time more likely to be 
hypertensive compared to younger middle age Asians.  
Based from this analysis, I rejected the null hypothesis and therefore accepted the 
alternative hypothesis.  There was an association between age and hypertension among a 
sample of middle aged Asians living in San Jose, CA. 
Research question 3.  What is the association between gender and hypertension 
among a sample of middle aged Asians living in San Jose, CA? 
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A binary logistic regression analysis was conducted to determine the association 
between gender and hypertension among a sample of middle aged Asians living in San 
Jose, CA.  There were 462 cases included in the analysis.  
Table 10 showed the logistic coefficient, Wald test and odds ratio of the predictor.  
Table 9 
Logistic Regression Analysis Between Gender and Hypertension 
Variables in equation 








Step 1a Gender -.430 .211 4.160 1 .041 .650 .430 .983 
 Constant 1.070 .169 40.053 1 .000 2.915   
Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable(s) entered on Step 1: Gender 
 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, gender had no significant association with hypertension, x2 
(1, N = 462) = 4.245, p = .039.  Gender recorded an odds ratio of .650. Based from this 
analysis, I failed to reject the null hypothesis. 
Research question 4.  What is the association between smoking status and 
hypertension among a sample of middle aged Asians living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between smoking status and hypertension among a sample of middle aged Asians living 
in San Jose, CA.  There were 462 cases included in the analysis.   





Logistic Regression Analysis Between Smoking Status and Hypertension 
 Variables in equation   
















-.139 .245 .321 1 .571 .871 .539 1.406 
 Constant .832 .114 53.500 1 .000 2.297   
Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable (s) entered on Step 1:Smoking status 
 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, smoking status had no significant association with 
hypertension, x2 (1, N = 462) = 3.18, p = .573.  Smoking status recorded an odds ratio of 
.871.  Based from this analysis, I failed to reject the null hypothesis. 
Research question 5.  What is the association between body mass index (BMI) 
and hypertension among a sample of middle aged Asians living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between body mass index (BMI) and hypertension among a sample of middle aged 
Asians living in San Jose, CA.  There were 462 cases included in the analysis.   




Logistic Regression Analysis Between BMI and Hypertension 
 Variables in equation   










Step 1a BMI -.025 .019 1.775 1 .183 .975 .939 1.012 
 Consta
nt 
1.480 .520 8.085 1 .004 4.392   
Note. BMI= body mass index; S.E. = standard error; df = degrees of freedom; Sig = 
significance; C.I. = confidence interval. a.Variable(s) entered on Step 1:BMI 
 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, BMI had no significant association with hypertension, x2 
(1, N = 462) = 1.768, p = .184.  BMI recorded an odds ratio of .975.  Based from this 
analysis, I failed to reject the null hypothesis. 
Research question 6.  What is the association between Mallampati Score (MS) 
and hypertension among a sample of middle aged Asians living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between Mallampati Score (MS) and hypertension among a sample of middle aged 
Asians living in San Jose, CA.  There were 462 cases included in the analysis.   





Logistic Regression Analysis Between Mallampati Score and Hypertension 
Variables in equation 










Step 1a Mallampati .251 .159 2.479 1 .115 1.285 .940 1.757 
 Constant -.125 .595 .044 1 .834 .882   
Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable(s) entered on Step 1:Mallampati 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, Mallampati Score had no significant association with 
hypertension, x2 (1, N = 462) = 1.768, p = .184.  Mallampati Score recorded an odds ratio 
of 1.285. Based from this analysis, I failed to reject the null hypothesis. 
Research question 7.  What is the association between Epworth Sleepiness Scale 
(ESS) and hypertension among a sample of middle aged Asian living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between Epworth Sleepiness Scale (ESS) and hypertension among a sample of middle 
aged Asian living in San Jose, CA.  There were 462 cases included in the analysis.   




Logistic Regression Analysis Between Epworth Sleepiness Scale 
  Variables in equation  










Step 1a Epworth -.039 .023 2.821 1 .093 .962 .919 1.007 
 Constant 1.282 .306 17.534 1 .000 3.604   
Note: S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable(s) entered on Step 1:Epworth  
 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, Epworth Sleepiness Scale had no significant association 
with hypertension, x2 (1, N = 462) = 2.870. p = .090.  Epworth Sleepiness Scale recorded 
an odds ratio of .962.  Based from this analysis, I failed to reject the null hypothesis. 
Research question 8.  What is the association between Apnea-Hypopnea Index 
(AHI) and hypertension among a sample of middle aged Asians living in San Jose, CA? 
A binary logistic regression analysis was conducted to determine the association 
between Apnea-Hypopnea Index (AHI) and hypertension among a sample of middle aged 
Asians living in San Jose, CA.  There were 462 cases included in the analysis.   





Logistic Regression Analysis Between Apnea-Hypopnea Index (AHI) and Hypertension 
Variables in equation 








Step 1a AHI -.001 .004 .071 1 .789 .999 .991 1.007 
 Constant .835 .159 27.491 1 .000 2.305   
Note: AHI = Apnea-Hypopnea Index;  S.E. = standard error; df = degrees of freedom; Sig 
= significance; C.I. = confidence interval. a.Variable (s) entered on Step 1:AHI 
 
 
Using a .05 criterion for statistical significance, in a sample of middle aged 
Asians living in San Jose, CA, Apnea Hypopnea Index had no significant association 
with hypertension, x2 (1, N = 462) = 6.974. p = .790.  Apnea Hypopnea Index recorded an 
odds ratio of .999.  Based from this analysis, I failed to reject the null hypothesis. 
A multiple regression analysis was conducted to determine the association of 
OSA and other risk factors as related to hypertension among middle-aged (40-60+ years 
old) Asians living in San Jose, CA.  There were 462 cases included in the analysis.  Table 
16 showed the logistic coefficient, Wald test and odds ratio of the predictors.  Table 16 





Summary of Results of the Logistic Regression Analysis 
  Variables in equation  










 OSA(1) -.541 .457 1.400 1 .237 .582 .237 1.427 
 Age .099 .011 87.808 1 .000 1.104 1.082 1.128 
 Gender .396 .282 1.972 1 .160 1.486 .855 2.581 
 Smoking 
status 
-.245 .302 .660 1 .417 .783 .433 1.414 
Step 1a BMI .043 .024 3.232 1 .072 1.044 .996 1.095 
 Mallampati .481 .204 5.541 1 .019 1.618 1.084 2.414 
 Epworth 
Scale 
-.025 .027 .866 1 .352 .975 .926 1.028 
 AHI -.005 .005 .733 1 .392 .995 .985 1.006 
 Constant 7.166 1.320 29.490 1 .000 .001   
Note. OSA= obstructive sleep apnea; AHI = Apnea-Hypopnea Index; BMI= body mass 
index; S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. = 
confidence interval. a.Variable(s) entered on Step 1: OSA, Age, Gender, Smoking status, 
BMI , Mallampati score, Epworth Scale, AHI 
 
Using a .05 criterion for statistical significance, in a sample of middle-aged 
Asians living in San Jose, CA, age had significant association with hypertension, p = 
.000.  Age recorded an odds ratio of 1.104.  Mallampati score had also a significant 
association with hypertension, p = .019. Mallampati score recorded an odds ratio of 
1.618. Based from this analysis, age and Mallampati score had significant association to 




This quantitative cross sectional study showed that OSA is associated with 
hypertension among middle aged Asians living in San Jose, CA.  This result were based 
from the analysis of  electronic and paper medical records of 462 patients randomly 
selected from three sleep study centers in San Jose, CA.  The logistic regression analysis 
also determined the prevalence rate of OSA in association with hypertension together 
with other risk factors including age, gender, smoking status, ESS, BMI, MSS, and AHI.  
The model containing the eight variables (OSA, age, gender, smoking status, BMI, 
Mallampati score, Epworth Sleepiness Scale, and Apnea-Hypopnea Index) were 
statistically significant, x2 (8, N = 462) = 139.549, p < .000.  The model as a whole 
explained 26.1% (Cox and Snell R square) and 36.7% (Nagelkerke R squared) of the 
variance in OSA association with hypertension and correctly classified 79.2% of the 
cases.  Age was the strongest predictor.  Based from the results of the multiple logistic 
regression analysis, age and Mallampati score had significant association to OSA in 
relation to hypertension among middle-aged Asians living in San Jose, CA. 





Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The goal of this study was to understand the prevalence of OSA and hypertension 
among Asians.  There are no published scientific reports on the general prevalence of 
OSA among Asians. OSA poses significant CVD burden. This imposes an important 
health crisis in a county of Santa Clara, where out of the 18 million residents 33.7% are 
Asians (U.S Census Data, 2012).  In order to understand the burden of these diseases, 
there is a need to understand what the prevalence of OSA and hypertension among 
Asians is.  Hence, the purpose of the study was to address this gap and to determine the 
role of other risk factors, such as age, gender, smoking, body mass index (BMI), 
Mallampati score (MS), Epworth Sleepiness Scale (ESS), and Apnea-Hypopnea Index 
(AHI), that influence the prevalence rate of OSA and its association with hypertension 
among middle aged Asians residing in San Jose, CA. 
This chapter provides the summation of the findings, conclusions, and 
recommendations based on the results on the quantitative cross-sectional study of the 
prevalence of OSA among middle aged Asians in Santa Clara County using paper and 
electronic medical records.  Data collection started in July 2014 and ended in October 
2014.  In order to ensure that data interpretation and analysis were impartial, I used 
logistic regression analysis to determine the prevalence of OSA and the association of 
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different variables.  The odds ratios (ORs) of OSA association with hypertension were 
calculated for ethnicity, age, gender, smoking, BMI, MSS, ESS, and AHI.  
Descriptive statistics were performed in the defined categorical variables in the 
study.  Frequency tabulation was used for gender, sex, race, smoking, and alcohol 
history, elevated blood pressure, and history of hypertension.  Descriptive statistics for 
continuous variables (e.g., age) which enlisted the summary statistics included n, mean, 
median, standard deviation, and range.  The study also included the use of tables to 
describe and explore the data. 
Statement of the Problem 
The main purpose of this quantitative cross-sectional study was to determine (a) 
the prevalence rate of OSA among middle-aged Asian patients (Chinese, Filipino, 
Vietnamese, Asian Indians, Korean, Taiwanese, Japanese, and Singaporean) in San Jose, 
CA.; (b) the association between OSA and hypertension, and (c) the association of other 
risk factors: age, gender, smoking, body mass index (BMI); Mallampati score (MS), the 
Epworth Sleepiness Scale (ESS), and Apnea-Hypopnea Index (AHI) with hypertension as 
the outcome.  
This quantitative cross-sectional study showed that OSA is associated with 
hypertension among middle-aged Asians living in San Jose, CA.  This result were based 
from the analysis of  paper and electronic medical records of 462 patients randomly 
selected from three sleep study centers in San Jose, CA.  The logistic regression analysis 
also determined the prevalence rate of OSA in association with hypertension together 
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with other risk factors including age, gender, smoking status, ESS, BMI, MSS, and AHI.  
The model containing the eight variables (OSA, age, gender, smoking status, BMI, 
Mallampati score, Epworth Sleepiness Scale, Apnea-Hypopnea Index) was statistically 
significant, x2 (8, N = 462) = 139.549, p < .000.  The model as a whole explained 26.1% 
(Cox and Snell R square) and 36.7% (Nagelkerke R squared) of the variance in OSA 
association with hypertension and correctly classified 79.2% of the cases.  Age was the 
strongest predictor. 
Interpretation of Findings 
The results of this study established verifications from other studies that OSA is 
common and associated with hypertension among Asian patients.  Similarly, this study 
also showed that among Asian patients with OSA, the association with hypertension is 
significantly increased with advancing age (Bixler et al., 2000; Drager et al., 2010; 
Young et al., 2004).  This study also adds further proof that weight as measured by body 
mass index (BMI) is not highly associated among OSA Asian patients with hypertension 
compared to other OSA Caucasian patients with hypertension (Kim et al., 2013; Hla et 
al., 1994, Yoon, et al., 2009).  This particular finding was a stark contrast to the findings 
by Min et al., (2014).  Min et al., 2014 found that among men with moderate to severe 
OSA, age was not associated with hypertension while neck circumference was positively 
correlated with OSA associated hypertension (Hla et al., 1994, p. 1310).  Additionally, 
gender, smoking status, Mallampati score, Epworth Sleepiness Scale, and Apnea-
Hypopnea Index had no significant association among OSA Asian patients with 
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hypertension.  However, Mallampati Score (MS) showed a trend towards suggesting that 
this particular risk factor could be considered as an important diagnostic tool in 
evaluating Asian patients with OSA and hypertension.  This particular finding supported 
the research findings by Li et al., (2000).  According to that study, the shorter anterior 
cranial base and acute cranial base flexure are more common among Far East Asian men 
compared to Caucasian men contributed to the high degree of association between OSA 
with hypertension (Li et al., 2000, p. 1691).  
The findings from this study supported the evidence that OSA is prevalent among 
Asians.  The study also showed that there is an association of OSA with hypertension. 
Given such association between OSA and hypertension among Asians, Asian patients 
should be screened, diagnosed, and treated appropriately to reduce the significant 
cardiovascular burden of this disease in the community. 
Limitations of the Study 
A limitation of the current study was that subjects were only sampled in Santa 
Clara County.  Additionally, the sample size was small.  Due to time and financial 
constraints, the study had to employ data obtained from paper and electronic medical 
records that were basically designed for clinical care and not research.  EMR was used 
because it provided easy access to patient data, large cohorts, patient level diagnosis, 
treatment data, billing and laboratory information.  However, limitations in the use of 
electronic medical records include information entered being decided by the provider, 
information entered in free text, scanned images, flexibility in terminology, a minimal 
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number of required fields, and unimportant data irrelevant to clinical care is missing 
(Terry et al., 2010).  Another limitation of the use of secondary data is the lack of clinical 
detail (Gallin & Ognibene, 2012).  This is especially true because certain EMR data sets 
contained clinical data relevant to physician payments (Gallin & Ognibene, 2012, p. 375).  
Another limitation of cross-sectional studies similar to this one is the inability of the 
researcher to provide a temporal sequence of the exposure and the outcome (Ho et al., 
2008).  The limitations associated with this data analysis also included variation in 
software platforms used by each clinic for their EMR systems, medical terminology, and 
clinical data, i.e., laboratory results, and units of measurements (Dean et al., 2009).  
However, the potential bias in the use of EMR as a source of secondary data was 
minimized by the random sampling of the subjects and the rigorous adherence to study 
protocol.   Additionally, this study did not include participants’ medical information such 
as medication use, patients’ medical history, sleep time, and other factors that might 
affect the association of OSA with hypertension.  The homogeneousness of the study 
population, the sample size, and the sampling convenience overall limited the 
generalizability of this study. 
Recommendations 
Prospective studies involving bigger cohorts should be conducted to determine 
accurately the prevalence of OSA among Asian patients compared to White populations.  
Ideally, future research should include analysis of the association of OSA and 
hypertension should be conducted among Asian and Caucasian patients while controlling 
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for age, gender, smoking status, body mass index (BMI), Mallampati score (MS), 
Epworth Sleepiness Scale (ESS), and Apnea Hypopnea Index (AHI). 
Social Change 
This study fostered to the epidemiologic understanding of OSA as the 
independent variable and hypertension as an outcome among middle aged Asians in San 
Jose, CA.  This study conducted a research on a disease that can generate valuable public 
health insight to the consequence of this disease to cardiovascular health among high risk 
middle-aged Asians.  This is critically important especially when studies involving OSA 
does not adequately synthesized or provide clarity into the health differences among 
Asian Americans.  Because there are still a great number of underdiagnosed and 
undertreated Asian patients in San Jose, CA, the results generated from this research can 
lead to successful physician identification, screening, treatment, and management of OSA 
and hypertension especially among high risks middle-aged Asians, thus creating positive 
social change for those individuals, their families, and their communities.  This study can 
advance social change by providing more justification for the need to conduct prospective 
large scale OSA studies among this vulnerable patient population who are definitely at 
risk for OSA and its health consequence.  This study can also advance social change by 
empowering this ethnic group to advocate for themselves and collectively challenge 
service providers, government agencies and other institutions to ensure equal access to 
healthcare, and available services.  Additionally, the results of this study would also 
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encourage positive social change by improving the health outcomes and the lives of 
Asians who have been suffering from OSA and hypertension for a long time. 
Conclusions 
OSA is common among middle aged Asians. OSA does increase the risk for 
hypertension among middle aged Asians in Santa Clara County.  This quantitative cross- 
sectional study showed that OSA is associated with hypertension among middle aged 
Asians living in San Jose, CA.  This particular research is very meaningful especially 
knowing that there are a number of Asians living in Santa Clara County that remains 
undiagnosed and untreated.   The question that remains, that possibly could be answered 
by other research, is what else aside from age that one should consider as an important 
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 Your approval # is 03-25-14-0153639. You will need to reference this number in 
your dissertation and in any future funding or publication submissions.   
Your IRB approval expires on March 24, 2015. One month before this expiration 
date, you will be sent a Continuing Review Form, which must be submitted if you wish to 
collect data beyond the approval expiration date.  
Please note that this letter indicates that the IRB has approved your research.  You 
may NOT begin the research phase of your doctoral study, however, until you have 
received the Notification of Approval to Conduct Research e-mail.  Once you have 
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received this notification by email, you may begin your data collection. Your IRB 
approval is contingent upon your adherence to the exact procedures described in the final 
version of the IRB application materials that have been submitted as of this date. This 
includes maintaining your current status with the university. Your IRB approval is only 
valid while you are an actively enrolled student at Walden University. If you need to take 
a leave of absence or are otherwise unable to remain actively enrolled, your IRB approval 
is suspended. Absolutely NO participant recruitment or data collection may occur while a 
student is not actively enrolled.  
Your IRB approval is contingent upon your adherence to the exact procedures 
described in the final version of the IRB application materials that have been submitted as 
of this date. If you need to make any changes to your research staff or procedures, you 
must obtain IRB approval by submitting the IRB Request for Change in Procedures 
Form.  You will receive confirmation with a status update of the request within 1 week of 
submitting the change request form and are not permitted to implement changes prior to 
receiving approval.  Please note that Walden University does not accept responsibility or 
liability for research activities conducted without the IRB's approval, and the University 
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will not accept or grant credit for student work that fails to comply with the policies and 
procedures related to ethical standards in research.  
When you submitted your IRB application, you a made commitment to 
communicate both discrete adverse events and general problems to the IRB within 1 
week of their occurrence/realization.  Failure to do so may result in invalidation of data, 
loss of academic credit, and/or loss of legal protections otherwise available to the 
researcher. 
 Both the Adverse Event Reporting form and Request for Change in Procedures 
form can be obtained at the IRB section of the Walden web site or by emailing 
irb@waldenu.edu: 
http://inside.waldenu.edu/c/Student_Faculty/StudentFaculty_4274.htm. 
 Researchers are expected to keep detailed records of their research activities (i.e., 
participant log sheets, completed consent forms, etc.) for the same period of time they 
retain the original data.  If, in the future, you require copies of the originally submitted 
IRB materials, you may request them from Institutional Review Board.  
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Both students and faculty are invited to provide feedback on this IRB experience 
at the link below:  
http://www.surveymonkey.com/s.aspx?sm=qHBJzkJMUx43pZegKlmdiQ_3d_3d 
Sincerely, 
Jenny Sherer, M.Ed., CIP 
Associate Director 




Office address for Walden University: 
100 Washington Avenue South 
Suite 900 
Minneapolis, MN 55401 
